Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4a
|
ENSMUSG00000017950.10 | hepatic nuclear factor 4, alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_163506695_163506887 | Hnf4a | 17 | 0.960165 | 0.88 | 1.2e-18 | Click! |
chr2_163552495_163552883 | Hnf4a | 2606 | 0.193989 | 0.87 | 2.7e-18 | Click! |
chr2_163574579_163574760 | Hnf4a | 24586 | 0.110276 | 0.85 | 1.2e-16 | Click! |
chr2_163547286_163547631 | Hnf4a | 270 | 0.871060 | 0.84 | 1.1e-15 | Click! |
chr2_163547032_163547209 | Hnf4a | 67 | 0.959077 | 0.84 | 1.5e-15 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_38191474_38191796 | 85.50 |
Fra10ac1 |
FRA10AC1 homolog (human) |
32503 |
0.13 |
chr8_123820339_123820501 | 78.90 |
Rab4a |
RAB4A, member RAS oncogene family |
6909 |
0.1 |
chr11_85695663_85695825 | 75.49 |
Bcas3os1 |
breast carcinoma amplified sequence 3, opposite strand 1 |
24000 |
0.17 |
chr17_36897864_36898191 | 74.49 |
Trim31 |
tripartite motif-containing 31 |
91 |
0.92 |
chr17_84137455_84137712 | 71.30 |
Gm19696 |
predicted gene, 19696 |
69 |
0.97 |
chr6_108486660_108487017 | 71.18 |
Mir7661 |
microRNA 7661 |
2905 |
0.22 |
chr4_46959884_46960074 | 70.51 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
31894 |
0.16 |
chr7_99224733_99224923 | 69.99 |
Mogat2 |
monoacylglycerol O-acyltransferase 2 |
13766 |
0.11 |
chr8_126573952_126574112 | 69.87 |
Gm26759 |
predicted gene, 26759 |
7062 |
0.22 |
chr13_41828353_41828524 | 69.73 |
Adtrp |
androgen dependent TFPI regulating protein |
15 |
0.97 |
chr14_27295918_27296098 | 69.37 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
40058 |
0.15 |
chr3_89136366_89136871 | 68.38 |
Pklr |
pyruvate kinase liver and red blood cell |
5 |
0.94 |
chr11_99106095_99106270 | 66.49 |
Tns4 |
tensin 4 |
16876 |
0.14 |
chr13_32849261_32849452 | 65.98 |
Serpinb1a |
serine (or cysteine) peptidase inhibitor, clade B, member 1a |
1808 |
0.27 |
chr17_26522781_26523080 | 65.20 |
Gm50274 |
predicted gene, 50274 |
2363 |
0.17 |
chr11_72504530_72504702 | 64.01 |
Spns3 |
spinster homolog 3 |
2173 |
0.25 |
chr14_122909488_122909660 | 63.29 |
4930594M22Rik |
RIKEN cDNA 4930594M22 gene |
3456 |
0.2 |
chr18_69303886_69304055 | 61.67 |
Tcf4 |
transcription factor 4 |
39386 |
0.15 |
chr4_141729393_141729567 | 61.63 |
Ddi2 |
DNA-damage inducible protein 2 |
6061 |
0.14 |
chr7_135528682_135528855 | 61.61 |
Clrn3 |
clarin 3 |
114 |
0.96 |
chr9_70277423_70277773 | 61.43 |
Myo1e |
myosin IE |
70230 |
0.1 |
chr10_17646491_17646713 | 60.36 |
Gm47771 |
predicted gene, 47771 |
11911 |
0.23 |
chr14_70057718_70058007 | 60.31 |
Gm33524 |
predicted gene, 33524 |
495 |
0.77 |
chr5_87536102_87536273 | 59.70 |
Sult1b1 |
sulfotransferase family 1B, member 1 |
35 |
0.96 |
chr2_151563228_151563425 | 59.52 |
Sdcbp2 |
syndecan binding protein (syntenin) 2 |
9296 |
0.13 |
chr18_7666095_7666259 | 58.17 |
Gm18763 |
predicted gene, 18763 |
26549 |
0.19 |
chr17_45994580_45994782 | 58.11 |
Vegfa |
vascular endothelial growth factor A |
26691 |
0.14 |
chr2_110305646_110305856 | 58.11 |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
10 |
0.98 |
chr4_118526862_118527114 | 57.45 |
2610528J11Rik |
RIKEN cDNA 2610528J11 gene |
11 |
0.96 |
chr11_51876996_51877477 | 57.07 |
Jade2 |
jade family PHD finger 2 |
19583 |
0.15 |
chr16_10471933_10472230 | 57.01 |
Ciita |
class II transactivator |
7978 |
0.17 |
chr4_86626545_86626882 | 56.97 |
Gm12551 |
predicted gene 12551 |
4538 |
0.17 |
chr2_173152672_173153088 | 56.69 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
168 |
0.95 |
chr13_109068552_109068866 | 56.20 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
47527 |
0.2 |
chr7_19676729_19676909 | 55.27 |
Apoc2 |
apolipoprotein C-II |
45 |
0.93 |
chr4_144902079_144902248 | 54.92 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
8944 |
0.21 |
chr5_4004856_4005069 | 54.86 |
Wdr46-ps |
Wdr46 retrotransposed pseudogene |
15956 |
0.17 |
chr11_57998862_57999212 | 54.76 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
10027 |
0.15 |
chr4_154294231_154294477 | 54.52 |
Arhgef16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
5538 |
0.18 |
chr7_110648735_110649013 | 54.11 |
Gm28863 |
predicted gene 28863 |
9516 |
0.15 |
chr2_74596190_74596369 | 54.10 |
Mrpl23-ps1 |
mitichondrial ribosomal protein L23, pseudogene 1 |
4370 |
0.12 |
chr5_117365976_117366161 | 54.08 |
Wsb2 |
WD repeat and SOCS box-containing 2 |
2546 |
0.16 |
chr12_50273359_50273533 | 54.02 |
Gm40418 |
predicted gene, 40418 |
153137 |
0.04 |
chr5_114970774_114971288 | 53.89 |
Hnf1a |
HNF1 homeobox A |
36 |
0.92 |
chr15_82794220_82794587 | 53.76 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr15_10985828_10986005 | 53.65 |
Amacr |
alpha-methylacyl-CoA racemase |
2510 |
0.23 |
chr4_130706306_130706479 | 53.55 |
Pum1 |
pumilio RNA-binding family member 1 |
42986 |
0.1 |
chr9_98307097_98307271 | 53.49 |
Gm28530 |
predicted gene 28530 |
5534 |
0.23 |
chr5_117360644_117361103 | 53.36 |
Wsb2 |
WD repeat and SOCS box-containing 2 |
149 |
0.92 |
chr1_88954795_88955088 | 53.21 |
Gm4753 |
predicted gene 4753 |
22622 |
0.19 |
chr17_84879231_84879533 | 53.17 |
Gm49982 |
predicted gene, 49982 |
23187 |
0.14 |
chr11_12411531_12411730 | 52.55 |
Cobl |
cordon-bleu WH2 repeat |
514 |
0.87 |
chr4_136452883_136453061 | 52.53 |
6030445D17Rik |
RIKEN cDNA 6030445D17 gene |
9278 |
0.15 |
chr7_134022577_134022797 | 52.48 |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
61422 |
0.12 |
chr6_120250946_120251217 | 52.21 |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
8438 |
0.22 |
chrX_103546911_103547094 | 52.13 |
Gm9157 |
predicted gene 9157 |
17519 |
0.07 |
chr11_76854936_76855099 | 52.02 |
Cpd |
carboxypeptidase D |
7999 |
0.2 |
chr17_83672792_83672995 | 51.90 |
Mta3 |
metastasis associated 3 |
33270 |
0.17 |
chr6_119405380_119405531 | 51.74 |
Adipor2 |
adiponectin receptor 2 |
12020 |
0.2 |
chr7_29989158_29989325 | 51.65 |
Zfp568 |
zinc finger protein 568 |
1468 |
0.24 |
chr2_50964143_50964317 | 51.56 |
Gm13498 |
predicted gene 13498 |
54546 |
0.16 |
chr6_101101939_101102287 | 51.53 |
Gm43942 |
predicted gene, 43942 |
42179 |
0.12 |
chr3_132629708_132629869 | 51.48 |
Gimd1 |
GIMAP family P-loop NTPase domain containing 1 |
32 |
0.98 |
chr1_153770335_153770651 | 51.22 |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
14509 |
0.1 |
chr1_191846706_191847003 | 50.83 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
19706 |
0.13 |
chr2_60269924_60270087 | 50.62 |
Rpl10a-ps4 |
ribosomal protein L10A, pseudogene 4 |
5569 |
0.17 |
chr9_17675645_17676038 | 50.52 |
Gm48848 |
predicted gene, 48848 |
43222 |
0.16 |
chr16_86389130_86389299 | 50.42 |
Gm32357 |
predicted gene, 32357 |
153043 |
0.04 |
chr2_160349673_160349862 | 50.23 |
Gm826 |
predicted gene 826 |
15605 |
0.22 |
chr5_114558159_114558686 | 50.18 |
Gm13790 |
predicted gene 13790 |
7133 |
0.17 |
chr16_34047647_34047931 | 50.07 |
Kalrn |
kalirin, RhoGEF kinase |
31295 |
0.17 |
chr1_60827104_60827305 | 50.03 |
Gm11581 |
predicted gene 11581 |
18088 |
0.12 |
chr7_135509348_135509534 | 49.96 |
Clrn3 |
clarin 3 |
19213 |
0.15 |
chr16_97606433_97606613 | 49.96 |
Tmprss2 |
transmembrane protease, serine 2 |
4446 |
0.24 |
chr14_32190742_32190922 | 49.73 |
Timm23 |
translocase of inner mitochondrial membrane 23 |
1125 |
0.28 |
chr2_32440732_32440921 | 49.59 |
Naif1 |
nuclear apoptosis inducing factor 1 |
9631 |
0.1 |
chr15_99099214_99099571 | 49.34 |
Dnajc22 |
DnaJ heat shock protein family (Hsp40) member C22 |
20 |
0.95 |
chr2_162992165_162992324 | 49.24 |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
4742 |
0.14 |
chr17_48456042_48456387 | 49.03 |
Unc5cl |
unc-5 family C-terminal like |
1313 |
0.33 |
chr4_132483387_132483538 | 48.94 |
Med18 |
mediator complex subunit 18 |
19541 |
0.09 |
chr16_13715138_13715299 | 48.65 |
Pla2g10os |
phospholipase A2, group X, opposite strand |
14618 |
0.11 |
chr2_147993432_147993622 | 48.45 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
17342 |
0.2 |
chr5_148014570_148014750 | 48.28 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
57318 |
0.12 |
chr3_109578246_109578630 | 48.15 |
Vav3 |
vav 3 oncogene |
4531 |
0.35 |
chr12_83708858_83709025 | 48.11 |
Psen1 |
presenilin 1 |
15698 |
0.12 |
chr7_121000144_121000451 | 48.05 |
Mfsd13b |
major facilitator superfamily domain containing 13B |
8474 |
0.09 |
chr8_123046809_123046960 | 48.00 |
2810013P06Rik |
RIKEN cDNA 2810013P06 gene |
4418 |
0.12 |
chr4_41331705_41331914 | 47.92 |
Gm26084 |
predicted gene, 26084 |
14142 |
0.1 |
chr9_109879302_109879597 | 47.49 |
Cdc25a |
cell division cycle 25A |
3143 |
0.15 |
chr1_91463477_91463649 | 47.25 |
Per2 |
period circadian clock 2 |
4239 |
0.13 |
chr12_17505834_17506128 | 47.21 |
Odc1 |
ornithine decarboxylase, structural 1 |
38813 |
0.11 |
chr1_93138609_93138975 | 47.19 |
Agxt |
alanine-glyoxylate aminotransferase |
1087 |
0.39 |
chr17_84672508_84672838 | 47.03 |
Abcg5 |
ATP binding cassette subfamily G member 5 |
1697 |
0.27 |
chr4_95793929_95794123 | 46.90 |
Fggy |
FGGY carbohydrate kinase domain containing |
24517 |
0.24 |
chr16_32740442_32740597 | 46.88 |
Muc4 |
mucin 4 |
4322 |
0.16 |
chr6_128661414_128661581 | 46.77 |
Clec2j |
C-type lectin domain family 2, member J |
323 |
0.67 |
chr6_24262621_24262890 | 46.76 |
Slc13a1 |
solute carrier family 13 (sodium/sulfate symporters), member 1 |
94663 |
0.08 |
chr7_120173616_120173940 | 46.29 |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
80 |
0.96 |
chr9_103049325_103049495 | 46.29 |
Gm22595 |
predicted gene, 22595 |
26944 |
0.12 |
chr12_91696294_91696631 | 46.13 |
Gm8378 |
predicted gene 8378 |
10349 |
0.16 |
chr6_100356770_100356925 | 46.03 |
Rybp |
RING1 and YY1 binding protein |
69362 |
0.09 |
chr7_46030144_46030478 | 45.87 |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
9 |
0.96 |
chr4_106582427_106583110 | 45.85 |
Gm12744 |
predicted gene 12744 |
6340 |
0.12 |
chr2_167805927_167806121 | 45.83 |
9230111E07Rik |
RIKEN cDNA 9230111E07 gene |
23971 |
0.13 |
chr18_69925366_69925673 | 45.83 |
Ccdc68 |
coiled-coil domain containing 68 |
51 |
0.98 |
chr16_50096307_50096470 | 45.58 |
Gm8824 |
predicted gene 8824 |
14685 |
0.3 |
chr17_6036583_6036754 | 45.56 |
Synj2 |
synaptojanin 2 |
11592 |
0.15 |
chr9_40465704_40465985 | 45.55 |
Gramd1b |
GRAM domain containing 1B |
280 |
0.89 |
chr7_113825581_113825788 | 45.50 |
Spon1 |
spondin 1, (f-spondin) extracellular matrix protein |
59510 |
0.13 |
chr2_91718387_91718718 | 45.47 |
Gm13776 |
predicted gene 13776 |
1133 |
0.37 |
chr7_127121537_127121725 | 45.42 |
Qprt |
quinolinate phosphoribosyltransferase |
387 |
0.68 |
chr10_62221209_62221363 | 45.22 |
Tspan15 |
tetraspanin 15 |
9965 |
0.16 |
chr6_129101731_129101898 | 45.08 |
Clec2e |
C-type lectin domain family 2, member e |
901 |
0.44 |
chr11_96030703_96030898 | 44.82 |
Gm24949 |
predicted gene, 24949 |
1878 |
0.17 |
chr17_35103351_35103693 | 44.62 |
Abhd16a |
abhydrolase domain containing 16A |
2668 |
0.07 |
chr2_68945021_68945208 | 44.59 |
Cers6 |
ceramide synthase 6 |
2146 |
0.25 |
chr6_88251435_88251608 | 44.46 |
1700031F10Rik |
RIKEN cDNA 1700031F10 gene |
25843 |
0.12 |
chr14_27101808_27102093 | 44.39 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
12949 |
0.19 |
chr1_164162872_164163051 | 44.35 |
Gm16588 |
predicted gene 16588 |
3618 |
0.15 |
chr18_43732076_43732380 | 44.18 |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
5329 |
0.2 |
chr5_114965371_114965535 | 44.18 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
3331 |
0.1 |
chr10_37325927_37326114 | 44.14 |
Gm26535 |
predicted gene, 26535 |
11466 |
0.26 |
chr5_73355501_73355893 | 44.09 |
Ociad2 |
OCIA domain containing 2 |
14669 |
0.11 |
chr3_125884958_125885165 | 43.95 |
Ugt8a |
UDP galactosyltransferase 8A |
30824 |
0.25 |
chr13_69410476_69410630 | 43.93 |
Gm44375 |
predicted gene, 44375 |
9156 |
0.19 |
chr11_54920213_54920377 | 43.71 |
Tnip1 |
TNFAIP3 interacting protein 1 |
780 |
0.57 |
chr7_112374112_112374374 | 43.58 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
102 |
0.98 |
chr1_58353623_58354036 | 43.57 |
Gm37607 |
predicted gene, 37607 |
32305 |
0.11 |
chr14_99281181_99281352 | 43.55 |
Gm4412 |
predicted gene 4412 |
10370 |
0.18 |
chr7_122226426_122226620 | 43.45 |
Chp2 |
calcineurin-like EF hand protein 2 |
4950 |
0.13 |
chr3_109962748_109962941 | 42.98 |
Gm12535 |
predicted gene 12535 |
55460 |
0.15 |
chr5_93024762_93024941 | 42.91 |
Gm25521 |
predicted gene, 25521 |
11712 |
0.13 |
chr2_128833545_128833736 | 42.89 |
Tmem87b |
transmembrane protein 87B |
7513 |
0.16 |
chr15_100436531_100436703 | 42.82 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
11545 |
0.1 |
chr1_74307263_74307457 | 42.65 |
Gm37931 |
predicted gene, 37931 |
488 |
0.58 |
chr19_4496672_4496836 | 42.64 |
2010003K11Rik |
RIKEN cDNA 2010003K11 gene |
1829 |
0.24 |
chr19_3320182_3320379 | 42.55 |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
2054 |
0.2 |
chr13_55391600_55392045 | 42.54 |
Slc34a1 |
solute carrier family 34 (sodium phosphate), member 1 |
6365 |
0.1 |
chr3_101526706_101526860 | 42.53 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
50777 |
0.11 |
chr18_32036989_32037188 | 42.34 |
Myo7b |
myosin VIIB |
127 |
0.94 |
chr17_45997101_45997335 | 42.33 |
Vegfa |
vascular endothelial growth factor A |
24154 |
0.14 |
chr5_77107268_77107436 | 42.32 |
Hopx |
HOP homeobox |
7769 |
0.13 |
chr10_25536040_25536288 | 42.27 |
Smlr1 |
small leucine-rich protein 1 |
22 |
0.74 |
chr6_48825123_48825318 | 42.26 |
Gm17834 |
predicted gene, 17834 |
6196 |
0.09 |
chr1_135235070_135235229 | 42.12 |
Gm4204 |
predicted gene 4204 |
3154 |
0.16 |
chr5_66081840_66082044 | 42.11 |
Rbm47 |
RNA binding motif protein 47 |
48 |
0.96 |
chr7_5087934_5088255 | 42.07 |
Epn1 |
epsin 1 |
1744 |
0.15 |
chr2_35616967_35617243 | 42.00 |
Dab2ip |
disabled 2 interacting protein |
4876 |
0.24 |
chr15_36811237_36811484 | 41.86 |
Gm25303 |
predicted gene, 25303 |
12589 |
0.15 |
chr19_53080200_53080382 | 41.86 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
486 |
0.78 |
chr16_38294755_38294927 | 41.82 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
17 |
0.97 |
chr4_123613397_123613915 | 41.75 |
Macf1 |
microtubule-actin crosslinking factor 1 |
87 |
0.96 |
chr10_52232158_52232456 | 41.70 |
Dcbld1 |
discoidin, CUB and LCCL domain containing 1 |
1312 |
0.42 |
chr2_72785445_72785619 | 41.69 |
6430710C18Rik |
RIKEN cDNA 6430710C18 gene |
14622 |
0.23 |
chr8_25716482_25716633 | 41.68 |
Plpp5 |
phospholipid phosphatase 5 |
3480 |
0.12 |
chr17_12700535_12700687 | 41.57 |
Igf2r |
insulin-like growth factor 2 receptor |
668 |
0.66 |
chr10_127603716_127603900 | 41.57 |
Gm16217 |
predicted gene 16217 |
7260 |
0.1 |
chr11_16804041_16804495 | 41.44 |
Egfros |
epidermal growth factor receptor, opposite strand |
26434 |
0.18 |
chr19_11235901_11236188 | 41.41 |
Ms4a12 |
membrane-spanning 4-domains, subfamily A, member 12 |
3596 |
0.15 |
chr9_64225851_64226002 | 41.38 |
Gm24106 |
predicted gene, 24106 |
403 |
0.69 |
chr14_101853787_101854063 | 41.38 |
Lmo7 |
LIM domain only 7 |
13106 |
0.26 |
chr14_55468559_55468710 | 41.36 |
Dhrs4 |
dehydrogenase/reductase (SDR family) member 4 |
10124 |
0.1 |
chr3_89133890_89134151 | 41.28 |
Pklr |
pyruvate kinase liver and red blood cell |
2122 |
0.13 |
chr11_115877272_115877624 | 41.27 |
Myo15b |
myosin XVB |
68 |
0.94 |
chr7_79171917_79172068 | 41.27 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
22932 |
0.15 |
chr10_26828769_26829098 | 41.22 |
Arhgap18 |
Rho GTPase activating protein 18 |
6331 |
0.25 |
chr5_115521515_115521712 | 41.13 |
Pxn |
paxillin |
1308 |
0.25 |
chr5_134548516_134548678 | 41.03 |
Gm42884 |
predicted gene 42884 |
3460 |
0.12 |
chr1_88419080_88419493 | 40.96 |
Spp2 |
secreted phosphoprotein 2 |
11880 |
0.15 |
chr11_115448120_115448406 | 40.91 |
Mir3968 |
microRNA 3968 |
203 |
0.84 |
chr1_163289168_163289456 | 40.90 |
Prrx1 |
paired related homeobox 1 |
88 |
0.97 |
chr19_17410542_17410839 | 40.85 |
Rfk |
riboflavin kinase |
13253 |
0.23 |
chr4_86690175_86690553 | 40.85 |
Plin2 |
perilipin 2 |
20304 |
0.17 |
chr7_37215531_37215889 | 40.80 |
Gm28075 |
predicted gene 28075 |
75169 |
0.09 |
chr3_118566891_118567114 | 40.78 |
Dpyd |
dihydropyrimidine dehydrogenase |
4816 |
0.2 |
chr3_119126127_119126300 | 40.75 |
Gm43410 |
predicted gene 43410 |
257969 |
0.02 |
chr10_28460055_28460228 | 40.50 |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
100010 |
0.08 |
chr9_122337749_122337929 | 40.48 |
Abhd5 |
abhydrolase domain containing 5 |
13769 |
0.13 |
chr1_157525893_157526398 | 40.46 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
2 |
0.97 |
chr12_84483239_84483558 | 40.44 |
Lin52 |
lin-52 homolog (C. elegans) |
26002 |
0.12 |
chr9_45202031_45202314 | 40.41 |
Tmprss4 |
transmembrane protease, serine 4 |
1814 |
0.2 |
chr19_3831760_3832172 | 40.37 |
Gm19209 |
predicted gene, 19209 |
9577 |
0.1 |
chr13_108494184_108494369 | 40.36 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
44267 |
0.18 |
chr8_36137384_36137657 | 40.35 |
Gm38414 |
predicted gene, 38414 |
18490 |
0.15 |
chr18_39044760_39044983 | 40.25 |
Gm15334 |
predicted gene 15334 |
50679 |
0.13 |
chr18_31934587_31934744 | 40.19 |
Lims2 |
LIM and senescent cell antigen like domains 2 |
849 |
0.51 |
chrX_13997930_13998082 | 40.19 |
Gm25552 |
predicted gene, 25552 |
12531 |
0.26 |
chr1_133376023_133376322 | 40.15 |
Etnk2 |
ethanolamine kinase 2 |
8885 |
0.14 |
chr13_41235986_41236147 | 40.13 |
Gm32063 |
predicted gene, 32063 |
279 |
0.79 |
chr9_114955462_114955619 | 40.08 |
Gpd1l |
glycerol-3-phosphate dehydrogenase 1-like |
21553 |
0.16 |
chr15_85776929_85777113 | 40.07 |
Ppara |
peroxisome proliferator activated receptor alpha |
4807 |
0.16 |
chr17_85028094_85028476 | 40.06 |
Slc3a1 |
solute carrier family 3, member 1 |
91 |
0.97 |
chr3_37158313_37158464 | 40.00 |
Gm12532 |
predicted gene 12532 |
24497 |
0.11 |
chr10_108111512_108111683 | 39.94 |
Gm47999 |
predicted gene, 47999 |
30835 |
0.2 |
chr7_46833351_46833657 | 39.92 |
Gm45308 |
predicted gene 45308 |
1040 |
0.32 |
chr9_111385891_111386090 | 39.91 |
Trank1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
354 |
0.88 |
chr6_67014340_67014544 | 39.75 |
Gm15644 |
predicted gene 15644 |
1957 |
0.21 |
chr7_110893979_110894323 | 39.70 |
Gm16336 |
predicted gene 16336 |
10834 |
0.16 |
chr17_84136322_84136524 | 39.65 |
Gm19696 |
predicted gene, 19696 |
463 |
0.8 |
chr5_53196448_53196965 | 39.64 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
16609 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.6 | 97.8 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
26.0 | 78.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
23.1 | 69.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
21.7 | 108.7 | GO:1904970 | brush border assembly(GO:1904970) |
21.3 | 63.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
18.7 | 56.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
17.4 | 87.1 | GO:0046618 | drug export(GO:0046618) |
16.7 | 50.0 | GO:1902896 | terminal web assembly(GO:1902896) |
15.6 | 62.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
15.3 | 45.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
14.8 | 74.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
14.3 | 43.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
13.4 | 40.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
12.8 | 38.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
12.2 | 36.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
12.0 | 12.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
11.9 | 35.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
11.6 | 34.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
11.4 | 45.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
11.4 | 68.2 | GO:0051639 | actin filament network formation(GO:0051639) |
11.3 | 181.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
11.0 | 11.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
10.7 | 32.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
10.2 | 41.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
10.2 | 30.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
9.9 | 39.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
9.7 | 29.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
9.6 | 28.8 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
9.6 | 38.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
9.6 | 47.9 | GO:0051610 | serotonin uptake(GO:0051610) |
9.4 | 56.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
9.0 | 27.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
8.7 | 34.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
8.6 | 43.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
8.5 | 42.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
8.5 | 25.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
8.3 | 41.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
8.3 | 41.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
8.3 | 41.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
8.2 | 57.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
8.1 | 40.5 | GO:0015879 | carnitine transport(GO:0015879) |
8.1 | 24.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
8.1 | 32.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
8.0 | 23.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
7.9 | 23.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
7.9 | 23.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
7.9 | 31.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
7.9 | 47.5 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
7.9 | 39.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
7.8 | 23.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
7.7 | 23.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
7.7 | 30.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
7.6 | 22.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
7.6 | 30.3 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
7.5 | 29.9 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
7.3 | 22.0 | GO:0000087 | mitotic M phase(GO:0000087) |
7.3 | 14.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
7.3 | 36.4 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
7.1 | 21.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
7.1 | 21.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
7.1 | 14.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
7.1 | 35.5 | GO:0070627 | ferrous iron import(GO:0070627) |
7.1 | 14.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
7.0 | 21.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
7.0 | 42.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
7.0 | 28.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
6.9 | 27.8 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
6.9 | 13.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
6.7 | 20.0 | GO:0042737 | drug catabolic process(GO:0042737) |
6.5 | 26.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
6.4 | 6.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
6.3 | 126.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
6.3 | 25.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
6.3 | 19.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
6.3 | 25.1 | GO:0048143 | astrocyte activation(GO:0048143) |
6.3 | 18.8 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
6.2 | 56.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
6.2 | 18.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
6.2 | 6.2 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
6.2 | 18.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
6.2 | 18.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
6.1 | 18.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
6.0 | 36.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
6.0 | 42.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
6.0 | 6.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
6.0 | 36.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
6.0 | 18.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
6.0 | 12.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
5.9 | 53.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
5.9 | 23.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
5.9 | 17.6 | GO:0036166 | phenotypic switching(GO:0036166) |
5.9 | 5.9 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
5.8 | 40.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
5.8 | 17.5 | GO:0030242 | pexophagy(GO:0030242) |
5.8 | 52.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
5.8 | 17.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
5.8 | 23.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
5.8 | 34.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
5.7 | 22.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
5.7 | 85.2 | GO:0051923 | sulfation(GO:0051923) |
5.6 | 27.9 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
5.6 | 11.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
5.6 | 16.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
5.6 | 16.7 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
5.6 | 33.3 | GO:0001842 | neural fold formation(GO:0001842) |
5.5 | 16.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
5.5 | 16.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
5.4 | 16.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
5.4 | 10.8 | GO:0015817 | histidine transport(GO:0015817) |
5.4 | 37.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
5.4 | 16.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
5.4 | 16.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
5.3 | 53.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
5.3 | 21.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
5.3 | 15.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
5.2 | 20.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
5.2 | 10.5 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
5.2 | 10.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
5.2 | 5.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
5.2 | 26.0 | GO:0097459 | iron ion import into cell(GO:0097459) |
5.2 | 31.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
5.2 | 20.7 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
5.2 | 15.5 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
5.2 | 20.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
5.1 | 56.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
5.1 | 10.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
5.1 | 25.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
5.1 | 20.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
5.0 | 15.1 | GO:0070268 | cornification(GO:0070268) |
5.0 | 15.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
5.0 | 29.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
5.0 | 14.9 | GO:0008050 | female courtship behavior(GO:0008050) |
4.9 | 14.8 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
4.9 | 14.8 | GO:0032439 | endosome localization(GO:0032439) |
4.9 | 14.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
4.9 | 9.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
4.9 | 29.3 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
4.8 | 19.4 | GO:0003383 | apical constriction(GO:0003383) |
4.8 | 38.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
4.8 | 19.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
4.8 | 14.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
4.8 | 4.8 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
4.8 | 14.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.7 | 4.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
4.7 | 19.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
4.7 | 18.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
4.7 | 18.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
4.7 | 14.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
4.7 | 14.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
4.7 | 18.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
4.7 | 32.9 | GO:0006108 | malate metabolic process(GO:0006108) |
4.7 | 28.1 | GO:0039535 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) regulation of RIG-I signaling pathway(GO:0039535) |
4.7 | 23.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
4.7 | 9.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
4.7 | 4.7 | GO:0061346 | cardiac right atrium morphogenesis(GO:0003213) non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
4.6 | 9.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
4.6 | 4.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
4.6 | 23.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
4.6 | 32.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
4.6 | 9.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
4.6 | 13.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.6 | 13.7 | GO:0015888 | thiamine transport(GO:0015888) |
4.5 | 4.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
4.5 | 4.5 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
4.5 | 9.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
4.5 | 17.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
4.5 | 13.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
4.5 | 13.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
4.5 | 17.8 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
4.4 | 22.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
4.4 | 8.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
4.4 | 8.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
4.4 | 4.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
4.4 | 8.7 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
4.3 | 17.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
4.3 | 13.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
4.3 | 12.9 | GO:0010446 | response to alkaline pH(GO:0010446) |
4.3 | 17.2 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
4.3 | 29.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
4.2 | 12.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
4.2 | 21.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
4.2 | 16.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
4.2 | 37.8 | GO:0034063 | stress granule assembly(GO:0034063) |
4.2 | 29.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
4.2 | 16.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
4.2 | 16.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
4.2 | 25.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
4.2 | 12.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.2 | 8.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
4.1 | 12.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
4.1 | 20.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
4.1 | 16.4 | GO:0009597 | detection of virus(GO:0009597) |
4.1 | 20.5 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
4.1 | 16.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.1 | 4.1 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
4.1 | 4.1 | GO:0035799 | ureter maturation(GO:0035799) |
4.0 | 8.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
4.0 | 12.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
4.0 | 4.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
4.0 | 4.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
4.0 | 4.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
4.0 | 4.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
4.0 | 31.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
4.0 | 4.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
3.9 | 7.9 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
3.9 | 19.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
3.9 | 23.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
3.9 | 11.8 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
3.9 | 7.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
3.9 | 7.8 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
3.9 | 3.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
3.9 | 11.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
3.9 | 15.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
3.9 | 19.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
3.9 | 7.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.9 | 19.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
3.9 | 11.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
3.8 | 15.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
3.8 | 15.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
3.8 | 22.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
3.8 | 15.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
3.8 | 11.4 | GO:0034214 | protein hexamerization(GO:0034214) |
3.8 | 18.9 | GO:0030913 | paranodal junction assembly(GO:0030913) |
3.8 | 3.8 | GO:0071404 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
3.8 | 11.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.8 | 7.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
3.8 | 7.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
3.8 | 7.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
3.7 | 7.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
3.7 | 33.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
3.7 | 7.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
3.7 | 7.4 | GO:0070836 | caveola assembly(GO:0070836) |
3.7 | 7.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
3.7 | 7.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.7 | 22.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
3.7 | 7.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
3.7 | 29.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
3.7 | 22.0 | GO:0060056 | mammary gland involution(GO:0060056) |
3.7 | 11.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
3.6 | 7.3 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
3.6 | 10.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
3.6 | 7.3 | GO:0051031 | tRNA transport(GO:0051031) |
3.6 | 21.8 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
3.6 | 7.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
3.6 | 7.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.6 | 35.9 | GO:0048664 | neuron fate determination(GO:0048664) |
3.6 | 14.4 | GO:0006116 | NADH oxidation(GO:0006116) |
3.6 | 14.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
3.6 | 28.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
3.6 | 21.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
3.6 | 7.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
3.6 | 49.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
3.5 | 3.5 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
3.5 | 24.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
3.5 | 7.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
3.5 | 7.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.5 | 24.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
3.5 | 10.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
3.5 | 3.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.5 | 24.5 | GO:0060068 | vagina development(GO:0060068) |
3.5 | 52.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
3.5 | 10.5 | GO:0061511 | centriole elongation(GO:0061511) |
3.5 | 14.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.5 | 34.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
3.5 | 10.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
3.5 | 10.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.5 | 10.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
3.5 | 10.4 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
3.5 | 17.3 | GO:0018101 | protein citrullination(GO:0018101) |
3.5 | 10.4 | GO:0097503 | sialylation(GO:0097503) |
3.4 | 24.1 | GO:0030033 | microvillus assembly(GO:0030033) |
3.4 | 17.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
3.4 | 17.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
3.4 | 10.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
3.4 | 3.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
3.4 | 3.4 | GO:0050904 | diapedesis(GO:0050904) |
3.4 | 3.4 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
3.4 | 30.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
3.4 | 13.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
3.4 | 6.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
3.4 | 16.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
3.4 | 3.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
3.4 | 6.7 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
3.4 | 13.4 | GO:0042268 | regulation of cytolysis(GO:0042268) |
3.4 | 3.4 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
3.3 | 10.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
3.3 | 3.3 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
3.3 | 9.9 | GO:0090009 | primitive streak formation(GO:0090009) |
3.3 | 3.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.3 | 26.3 | GO:0032060 | bleb assembly(GO:0032060) |
3.3 | 19.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
3.3 | 9.8 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
3.3 | 9.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
3.3 | 6.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
3.3 | 6.5 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
3.3 | 3.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
3.2 | 13.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
3.2 | 12.9 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
3.2 | 25.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
3.2 | 16.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
3.2 | 19.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
3.2 | 6.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.2 | 3.2 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
3.2 | 3.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.2 | 6.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
3.2 | 47.3 | GO:0050892 | intestinal absorption(GO:0050892) |
3.2 | 6.3 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
3.1 | 6.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
3.1 | 3.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
3.1 | 18.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
3.1 | 12.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
3.1 | 15.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
3.1 | 9.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
3.1 | 105.8 | GO:0006953 | acute-phase response(GO:0006953) |
3.1 | 9.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
3.1 | 9.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.1 | 12.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
3.1 | 18.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
3.1 | 34.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
3.1 | 9.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
3.1 | 21.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
3.1 | 21.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
3.1 | 6.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.1 | 6.2 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
3.1 | 27.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
3.1 | 27.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
3.1 | 15.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
3.1 | 12.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
3.0 | 6.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
3.0 | 6.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
3.0 | 6.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
3.0 | 6.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.0 | 3.0 | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
3.0 | 9.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
3.0 | 9.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
3.0 | 9.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
3.0 | 12.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
3.0 | 3.0 | GO:0042558 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound metabolic process(GO:0042558) tetrahydrobiopterin metabolic process(GO:0046146) |
3.0 | 45.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
3.0 | 18.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.0 | 3.0 | GO:2000209 | regulation of anoikis(GO:2000209) |
3.0 | 12.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
3.0 | 6.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
3.0 | 17.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
3.0 | 3.0 | GO:0051593 | response to folic acid(GO:0051593) |
2.9 | 11.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
2.9 | 8.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.9 | 5.9 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.9 | 5.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.9 | 26.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
2.9 | 8.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
2.9 | 5.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.9 | 8.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
2.9 | 11.6 | GO:0018214 | protein carboxylation(GO:0018214) |
2.9 | 8.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
2.9 | 8.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.9 | 14.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
2.9 | 2.9 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.9 | 8.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
2.9 | 2.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.9 | 8.6 | GO:0070295 | renal water absorption(GO:0070295) |
2.9 | 5.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.8 | 5.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
2.8 | 42.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
2.8 | 2.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.8 | 11.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
2.8 | 14.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.8 | 25.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
2.8 | 47.8 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
2.8 | 8.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.8 | 11.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.8 | 8.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
2.8 | 47.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
2.8 | 8.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
2.8 | 2.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
2.8 | 16.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.8 | 5.5 | GO:0071280 | cellular response to copper ion(GO:0071280) |
2.8 | 2.8 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
2.7 | 8.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
2.7 | 11.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
2.7 | 8.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
2.7 | 5.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
2.7 | 10.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
2.7 | 2.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
2.7 | 10.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.7 | 2.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
2.7 | 13.6 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
2.7 | 2.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.7 | 16.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
2.7 | 2.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.7 | 2.7 | GO:0033058 | directional locomotion(GO:0033058) |
2.7 | 8.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.7 | 2.7 | GO:0071725 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
2.7 | 34.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
2.7 | 5.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
2.7 | 5.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
2.7 | 8.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
2.7 | 8.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
2.7 | 21.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.7 | 5.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
2.7 | 37.2 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
2.7 | 8.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
2.6 | 10.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.6 | 15.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
2.6 | 7.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
2.6 | 5.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
2.6 | 2.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
2.6 | 7.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
2.6 | 10.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
2.6 | 5.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.6 | 2.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.6 | 2.6 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
2.6 | 7.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
2.6 | 7.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.6 | 7.8 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
2.6 | 7.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
2.6 | 5.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
2.6 | 5.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.6 | 2.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.6 | 7.7 | GO:0007567 | parturition(GO:0007567) |
2.6 | 5.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
2.6 | 5.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
2.6 | 12.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.6 | 5.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.5 | 50.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
2.5 | 5.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
2.5 | 2.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.5 | 2.5 | GO:0035973 | aggrephagy(GO:0035973) |
2.5 | 7.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
2.5 | 35.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
2.5 | 2.5 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) negative regulation of ATP biosynthetic process(GO:2001170) |
2.5 | 32.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.5 | 17.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.5 | 7.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
2.5 | 2.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
2.5 | 32.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.5 | 32.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
2.5 | 2.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.5 | 2.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.5 | 7.5 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
2.5 | 5.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.5 | 32.4 | GO:0008272 | sulfate transport(GO:0008272) |
2.5 | 24.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.5 | 17.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.5 | 2.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.5 | 2.5 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
2.5 | 5.0 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
2.5 | 17.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
2.5 | 4.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
2.5 | 2.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.5 | 2.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
2.4 | 7.3 | GO:0097286 | iron ion import(GO:0097286) |
2.4 | 12.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.4 | 9.7 | GO:0007296 | vitellogenesis(GO:0007296) |
2.4 | 9.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
2.4 | 7.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.4 | 4.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
2.4 | 9.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
2.4 | 9.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
2.4 | 12.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
2.4 | 130.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
2.4 | 7.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.4 | 7.2 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
2.4 | 16.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.4 | 19.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
2.4 | 21.6 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
2.4 | 12.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.4 | 7.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.4 | 9.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
2.4 | 19.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
2.4 | 9.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
2.4 | 33.4 | GO:0050779 | RNA destabilization(GO:0050779) |
2.4 | 16.7 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
2.4 | 2.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
2.4 | 19.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
2.4 | 7.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
2.4 | 4.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
2.4 | 19.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
2.4 | 30.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
2.4 | 11.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
2.4 | 2.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
2.4 | 4.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.4 | 35.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
2.3 | 14.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
2.3 | 11.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.3 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.3 | 7.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
2.3 | 7.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
2.3 | 2.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
2.3 | 4.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
2.3 | 4.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
2.3 | 7.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
2.3 | 4.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
2.3 | 37.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
2.3 | 2.3 | GO:0030239 | myofibril assembly(GO:0030239) |
2.3 | 2.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
2.3 | 9.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.3 | 18.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
2.3 | 6.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
2.3 | 9.2 | GO:0015871 | choline transport(GO:0015871) |
2.3 | 2.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
2.3 | 4.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
2.3 | 4.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
2.3 | 4.6 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
2.3 | 4.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.3 | 6.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
2.3 | 2.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
2.3 | 27.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
2.3 | 4.5 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
2.3 | 22.7 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
2.3 | 2.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.3 | 4.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
2.3 | 43.0 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
2.3 | 18.0 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
2.3 | 22.5 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
2.3 | 4.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.3 | 9.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.3 | 20.3 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
2.3 | 11.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
2.2 | 6.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
2.2 | 15.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.2 | 2.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.2 | 4.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
2.2 | 11.1 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
2.2 | 4.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
2.2 | 17.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.2 | 4.4 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
2.2 | 8.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.2 | 4.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
2.2 | 6.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.2 | 2.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.2 | 15.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
2.2 | 6.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
2.2 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.2 | 2.2 | GO:0030575 | nuclear body organization(GO:0030575) |
2.2 | 4.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
2.2 | 6.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.2 | 2.2 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
2.2 | 41.6 | GO:0048821 | erythrocyte development(GO:0048821) |
2.2 | 2.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
2.2 | 4.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
2.2 | 26.2 | GO:0051601 | exocyst localization(GO:0051601) |
2.2 | 6.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.2 | 2.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
2.2 | 23.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.2 | 2.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
2.2 | 6.5 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
2.2 | 8.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
2.2 | 4.3 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
2.2 | 4.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.2 | 4.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
2.1 | 2.1 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.1 | 6.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.1 | 19.3 | GO:0010842 | retina layer formation(GO:0010842) |
2.1 | 70.7 | GO:0060711 | labyrinthine layer development(GO:0060711) |
2.1 | 2.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
2.1 | 4.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
2.1 | 4.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
2.1 | 4.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.1 | 2.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
2.1 | 23.3 | GO:0006826 | iron ion transport(GO:0006826) |
2.1 | 4.2 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
2.1 | 6.4 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.1 | 6.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
2.1 | 2.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
2.1 | 12.7 | GO:0060613 | fat pad development(GO:0060613) |
2.1 | 6.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.1 | 16.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
2.1 | 10.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.1 | 14.7 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
2.1 | 8.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
2.1 | 18.8 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
2.1 | 8.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
2.1 | 10.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
2.1 | 6.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
2.1 | 6.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.1 | 2.1 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
2.1 | 2.1 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
2.1 | 14.5 | GO:0097421 | liver regeneration(GO:0097421) |
2.1 | 2.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
2.1 | 119.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
2.1 | 4.1 | GO:0030070 | insulin processing(GO:0030070) |
2.1 | 4.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
2.1 | 26.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.1 | 2.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
2.1 | 14.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
2.1 | 2.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
2.0 | 16.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
2.0 | 18.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
2.0 | 6.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.0 | 2.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
2.0 | 2.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
2.0 | 6.1 | GO:0007595 | lactation(GO:0007595) |
2.0 | 8.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
2.0 | 44.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
2.0 | 8.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.0 | 4.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.0 | 16.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.0 | 16.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
2.0 | 6.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.0 | 2.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
2.0 | 2.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
2.0 | 16.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
2.0 | 2.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
2.0 | 4.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
2.0 | 16.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
2.0 | 4.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
2.0 | 2.0 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
2.0 | 10.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.0 | 4.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
2.0 | 2.0 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
2.0 | 10.0 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
2.0 | 6.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.0 | 6.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
2.0 | 2.0 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
2.0 | 4.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
2.0 | 6.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.0 | 6.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
2.0 | 4.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.0 | 51.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
2.0 | 2.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
2.0 | 2.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.0 | 3.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
2.0 | 3.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.0 | 5.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
2.0 | 13.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
2.0 | 3.9 | GO:0008078 | mesodermal cell migration(GO:0008078) |
2.0 | 3.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
2.0 | 17.6 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
2.0 | 3.9 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.0 | 29.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
2.0 | 2.0 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.9 | 5.8 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.9 | 21.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.9 | 1.9 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
1.9 | 5.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.9 | 3.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.9 | 30.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.9 | 1.9 | GO:0048382 | mesendoderm development(GO:0048382) |
1.9 | 3.8 | GO:0001555 | oocyte growth(GO:0001555) |
1.9 | 13.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.9 | 5.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.9 | 5.7 | GO:0008355 | olfactory learning(GO:0008355) |
1.9 | 19.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
1.9 | 3.8 | GO:0032252 | secretory granule localization(GO:0032252) |
1.9 | 17.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.9 | 9.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.9 | 1.9 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.9 | 5.7 | GO:0008228 | opsonization(GO:0008228) |
1.9 | 1.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.9 | 1.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.9 | 18.9 | GO:0032400 | melanosome localization(GO:0032400) |
1.9 | 1.9 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.9 | 35.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
1.9 | 30.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.9 | 5.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.9 | 13.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.9 | 7.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.9 | 7.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.9 | 3.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
1.9 | 3.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.9 | 7.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.9 | 3.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.9 | 3.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.9 | 9.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.9 | 9.4 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
1.9 | 15.0 | GO:0098754 | detoxification(GO:0098754) |
1.9 | 3.7 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.9 | 9.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.9 | 31.8 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
1.9 | 7.5 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.9 | 3.7 | GO:0009642 | response to light intensity(GO:0009642) |
1.9 | 3.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.9 | 22.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.9 | 3.7 | GO:0016264 | gap junction assembly(GO:0016264) |
1.9 | 26.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
1.9 | 9.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
1.9 | 1.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.9 | 16.7 | GO:0006734 | NADH metabolic process(GO:0006734) |
1.9 | 27.8 | GO:0034340 | response to type I interferon(GO:0034340) |
1.9 | 9.3 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
1.8 | 9.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.8 | 1.8 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.8 | 25.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
1.8 | 5.5 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
1.8 | 25.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
1.8 | 7.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.8 | 1.8 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
1.8 | 25.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
1.8 | 7.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.8 | 1.8 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
1.8 | 5.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.8 | 7.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.8 | 5.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.8 | 3.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.8 | 7.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.8 | 5.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
1.8 | 3.6 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.8 | 12.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.8 | 9.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.8 | 9.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.8 | 9.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.8 | 1.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.8 | 1.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.8 | 1.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.8 | 7.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.8 | 3.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.8 | 7.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
1.8 | 16.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.8 | 14.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.8 | 3.6 | GO:0007525 | somatic muscle development(GO:0007525) |
1.8 | 1.8 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
1.8 | 9.0 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
1.8 | 5.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.8 | 5.4 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
1.8 | 5.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.8 | 7.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.8 | 3.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.8 | 5.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.8 | 3.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.8 | 8.9 | GO:0000237 | leptotene(GO:0000237) |
1.8 | 5.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.8 | 5.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.8 | 42.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
1.8 | 5.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.8 | 8.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.8 | 49.4 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
1.8 | 5.3 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
1.8 | 12.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.8 | 1.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.8 | 7.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.8 | 8.8 | GO:0007379 | segment specification(GO:0007379) |
1.8 | 3.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.8 | 14.1 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
1.8 | 22.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
1.8 | 21.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
1.8 | 1.8 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
1.8 | 12.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.8 | 24.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.8 | 3.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.8 | 17.5 | GO:0045851 | pH reduction(GO:0045851) |
1.8 | 3.5 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
1.7 | 7.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.7 | 1.7 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
1.7 | 3.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.7 | 3.5 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
1.7 | 6.9 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
1.7 | 1.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.7 | 1.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.7 | 18.9 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
1.7 | 8.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
1.7 | 1.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.7 | 8.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.7 | 6.9 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
1.7 | 5.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.7 | 29.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.7 | 42.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
1.7 | 6.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.7 | 8.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.7 | 5.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.7 | 8.5 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
1.7 | 6.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.7 | 3.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.7 | 6.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.7 | 13.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
1.7 | 11.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.7 | 3.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.7 | 16.9 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
1.7 | 3.4 | GO:0070542 | response to fatty acid(GO:0070542) |
1.7 | 10.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.7 | 5.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.7 | 3.4 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
1.7 | 5.0 | GO:0060023 | soft palate development(GO:0060023) |
1.7 | 5.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.7 | 5.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.7 | 10.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.7 | 1.7 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.7 | 6.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.7 | 8.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.7 | 6.6 | GO:0046697 | decidualization(GO:0046697) |
1.7 | 3.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.7 | 3.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.7 | 3.3 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.7 | 33.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
1.7 | 8.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
1.7 | 5.0 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
1.7 | 1.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
1.7 | 14.9 | GO:0015893 | drug transport(GO:0015893) |
1.7 | 5.0 | GO:0015705 | iodide transport(GO:0015705) |
1.6 | 8.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.6 | 1.6 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
1.6 | 4.9 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
1.6 | 6.6 | GO:0051026 | chiasma assembly(GO:0051026) |
1.6 | 6.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.6 | 3.3 | GO:0043084 | penile erection(GO:0043084) |
1.6 | 54.2 | GO:0045576 | mast cell activation(GO:0045576) |
1.6 | 1.6 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
1.6 | 4.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.6 | 3.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
1.6 | 8.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.6 | 4.9 | GO:0040031 | snRNA modification(GO:0040031) |
1.6 | 9.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.6 | 3.3 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
1.6 | 4.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.6 | 3.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.6 | 3.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.6 | 3.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.6 | 3.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.6 | 8.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
1.6 | 4.9 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.6 | 8.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.6 | 19.5 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
1.6 | 8.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
1.6 | 1.6 | GO:0003091 | renal water homeostasis(GO:0003091) |
1.6 | 1.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.6 | 1.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.6 | 3.2 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
1.6 | 6.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.6 | 6.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.6 | 1.6 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
1.6 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.6 | 6.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.6 | 3.2 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
1.6 | 4.8 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
1.6 | 8.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.6 | 14.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.6 | 6.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
1.6 | 22.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
1.6 | 6.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.6 | 35.1 | GO:0098930 | axonal transport(GO:0098930) |
1.6 | 1.6 | GO:0045778 | positive regulation of ossification(GO:0045778) |
1.6 | 11.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.6 | 9.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.6 | 4.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.6 | 1.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.6 | 4.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.6 | 6.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.6 | 15.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.6 | 4.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.6 | 1.6 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.6 | 3.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.6 | 6.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.6 | 4.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.6 | 135.3 | GO:0007596 | blood coagulation(GO:0007596) |
1.6 | 6.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.6 | 4.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.6 | 1.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
1.6 | 7.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.6 | 3.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.5 | 3.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.5 | 1.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.5 | 33.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
1.5 | 4.6 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
1.5 | 1.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.5 | 6.1 | GO:0010039 | response to iron ion(GO:0010039) |
1.5 | 7.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.5 | 3.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.5 | 3.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.5 | 4.6 | GO:0009838 | abscission(GO:0009838) |
1.5 | 3.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.5 | 10.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.5 | 4.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.5 | 4.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.5 | 15.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
1.5 | 1.5 | GO:0035690 | cellular response to drug(GO:0035690) |
1.5 | 12.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.5 | 15.1 | GO:0051180 | vitamin transport(GO:0051180) |
1.5 | 12.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.5 | 9.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.5 | 3.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.5 | 3.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.5 | 1.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
1.5 | 4.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.5 | 1.5 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
1.5 | 8.9 | GO:0035878 | nail development(GO:0035878) |
1.5 | 10.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.5 | 1.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.5 | 4.5 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
1.5 | 3.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
1.5 | 1.5 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
1.5 | 1.5 | GO:0070989 | oxidative demethylation(GO:0070989) |
1.5 | 3.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.5 | 11.8 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
1.5 | 10.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
1.5 | 2.9 | GO:0002159 | desmosome assembly(GO:0002159) |
1.5 | 5.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.5 | 5.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.5 | 13.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
1.5 | 1.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.5 | 1.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.5 | 4.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.5 | 5.8 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
1.5 | 1.5 | GO:0032202 | telomere assembly(GO:0032202) |
1.5 | 32.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.5 | 17.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.5 | 4.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.4 | 8.7 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
1.4 | 1.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
1.4 | 1.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.4 | 4.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.4 | 4.3 | GO:0042637 | catagen(GO:0042637) |
1.4 | 2.9 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
1.4 | 7.2 | GO:0003352 | regulation of cilium movement(GO:0003352) |
1.4 | 4.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.4 | 18.7 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
1.4 | 5.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.4 | 1.4 | GO:0032366 | intracellular sterol transport(GO:0032366) |
1.4 | 14.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.4 | 1.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.4 | 21.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.4 | 4.3 | GO:1902268 | polyamine transport(GO:0015846) negative regulation of polyamine transmembrane transport(GO:1902268) |
1.4 | 45.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.4 | 7.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
1.4 | 1.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
1.4 | 4.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
1.4 | 11.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.4 | 2.8 | GO:0035483 | gastric emptying(GO:0035483) |
1.4 | 4.3 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.4 | 2.8 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.4 | 4.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.4 | 1.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.4 | 2.8 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.4 | 2.8 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.4 | 2.8 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.4 | 2.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.4 | 7.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.4 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.4 | 7.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.4 | 2.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.4 | 22.5 | GO:0051297 | centrosome organization(GO:0051297) |
1.4 | 4.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.4 | 2.8 | GO:0050955 | thermoception(GO:0050955) |
1.4 | 11.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.4 | 2.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.4 | 5.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
1.4 | 2.8 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.4 | 1.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.4 | 2.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.4 | 1.4 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.4 | 1.4 | GO:0071224 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) cellular response to peptidoglycan(GO:0071224) |
1.4 | 4.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.4 | 4.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.4 | 5.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
1.4 | 17.8 | GO:0001523 | retinoid metabolic process(GO:0001523) |
1.4 | 6.8 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
1.4 | 1.4 | GO:0002254 | kinin cascade(GO:0002254) |
1.4 | 2.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.4 | 42.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
1.4 | 1.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.4 | 24.4 | GO:0014823 | response to activity(GO:0014823) |
1.4 | 10.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.4 | 20.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.4 | 5.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.3 | 4.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.3 | 1.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.3 | 1.3 | GO:0031639 | plasminogen activation(GO:0031639) |
1.3 | 1.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.3 | 2.7 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
1.3 | 12.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
1.3 | 4.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.3 | 2.7 | GO:0050957 | equilibrioception(GO:0050957) |
1.3 | 13.4 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
1.3 | 20.1 | GO:0007623 | circadian rhythm(GO:0007623) |
1.3 | 1.3 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.3 | 6.7 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
1.3 | 2.7 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
1.3 | 13.4 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.3 | 1.3 | GO:0010042 | response to manganese ion(GO:0010042) |
1.3 | 1.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.3 | 2.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.3 | 1.3 | GO:0032528 | microvillus organization(GO:0032528) |
1.3 | 14.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.3 | 4.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.3 | 19.9 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
1.3 | 4.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 1.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.3 | 1.3 | GO:0090382 | phagosome maturation(GO:0090382) |
1.3 | 1.3 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.3 | 5.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.3 | 7.9 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
1.3 | 15.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
1.3 | 2.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.3 | 22.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.3 | 5.2 | GO:0006983 | ER overload response(GO:0006983) |
1.3 | 1.3 | GO:0007494 | midgut development(GO:0007494) |
1.3 | 9.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.3 | 10.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
1.3 | 3.9 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
1.3 | 29.9 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
1.3 | 6.5 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.3 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.3 | 11.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.3 | 16.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
1.3 | 3.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.3 | 2.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
1.3 | 2.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
1.3 | 28.4 | GO:1901998 | toxin transport(GO:1901998) |
1.3 | 7.7 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
1.3 | 3.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.3 | 5.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
1.3 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.3 | 9.0 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
1.3 | 2.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.3 | 10.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.3 | 1.3 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
1.3 | 5.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
1.3 | 3.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.3 | 7.7 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
1.3 | 8.9 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
1.3 | 6.4 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
1.3 | 8.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.3 | 1.3 | GO:0044849 | estrous cycle(GO:0044849) |
1.3 | 7.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.3 | 1.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.3 | 2.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.3 | 15.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.3 | 5.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.3 | 5.0 | GO:0006968 | cellular defense response(GO:0006968) |
1.3 | 11.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.3 | 3.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.3 | 10.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
1.3 | 2.5 | GO:0033762 | response to glucagon(GO:0033762) |
1.3 | 5.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
1.3 | 2.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.3 | 2.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.2 | 5.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.2 | 11.2 | GO:0034389 | lipid particle organization(GO:0034389) |
1.2 | 42.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
1.2 | 10.0 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
1.2 | 7.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.2 | 3.7 | GO:0051775 | response to redox state(GO:0051775) |
1.2 | 1.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.2 | 2.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.2 | 3.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.2 | 13.7 | GO:0055088 | lipid homeostasis(GO:0055088) |
1.2 | 14.9 | GO:0030488 | tRNA methylation(GO:0030488) |
1.2 | 6.2 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
1.2 | 30.9 | GO:0007569 | cell aging(GO:0007569) |
1.2 | 1.2 | GO:0021586 | pons maturation(GO:0021586) |
1.2 | 9.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.2 | 3.7 | GO:0009650 | UV protection(GO:0009650) |
1.2 | 2.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.2 | 2.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.2 | 11.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
1.2 | 6.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.2 | 3.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.2 | 6.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.2 | 1.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.2 | 3.6 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
1.2 | 6.1 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.2 | 6.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.2 | 3.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
1.2 | 41.0 | GO:0007566 | embryo implantation(GO:0007566) |
1.2 | 7.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.2 | 4.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.2 | 3.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
1.2 | 4.8 | GO:0007000 | nucleolus organization(GO:0007000) |
1.2 | 1.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
1.2 | 1.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
1.2 | 9.5 | GO:0006575 | cellular modified amino acid metabolic process(GO:0006575) |
1.2 | 7.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.2 | 6.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.2 | 3.6 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
1.2 | 7.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.2 | 3.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.2 | 9.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.2 | 21.4 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
1.2 | 2.4 | GO:0043627 | response to estrogen(GO:0043627) |
1.2 | 23.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
1.2 | 16.5 | GO:0044804 | nucleophagy(GO:0044804) |
1.2 | 7.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
1.2 | 5.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.2 | 1.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.2 | 1.2 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 21.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
1.2 | 1.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.2 | 3.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
1.2 | 3.5 | GO:0014741 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
1.2 | 3.5 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
1.2 | 15.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.2 | 9.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
1.2 | 1.2 | GO:0044241 | lipid digestion(GO:0044241) |
1.2 | 11.6 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.2 | 3.5 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.2 | 3.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.2 | 7.0 | GO:0080111 | DNA demethylation(GO:0080111) |
1.2 | 1.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.2 | 2.3 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
1.2 | 2.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.2 | 5.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 2.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
1.1 | 2.3 | GO:0060290 | transdifferentiation(GO:0060290) |
1.1 | 1.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.1 | 2.3 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.1 | 6.8 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
1.1 | 10.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.1 | 2.3 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
1.1 | 3.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.1 | 2.3 | GO:0051261 | protein depolymerization(GO:0051261) |
1.1 | 1.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.1 | 13.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.1 | 18.0 | GO:0045214 | sarcomere organization(GO:0045214) |
1.1 | 2.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.1 | 1.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.1 | 24.6 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.1 | 2.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.1 | 5.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.1 | 1.1 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
1.1 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.1 | 13.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
1.1 | 8.9 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
1.1 | 2.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.1 | 14.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.1 | 8.9 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 2.2 | GO:0030576 | Cajal body organization(GO:0030576) |
1.1 | 6.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.1 | 9.9 | GO:0033198 | response to ATP(GO:0033198) |
1.1 | 6.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.1 | 1.1 | GO:0030048 | actin filament-based movement(GO:0030048) |
1.1 | 2.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
1.1 | 49.5 | GO:0006909 | phagocytosis(GO:0006909) |
1.1 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.1 | 9.9 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
1.1 | 14.2 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
1.1 | 3.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
1.1 | 3.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.1 | 4.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
1.1 | 7.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.1 | 2.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
1.1 | 2.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
1.1 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
1.1 | 2.2 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
1.1 | 3.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.1 | 2.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.1 | 3.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.1 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.1 | 2.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
1.1 | 4.3 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.1 | 2.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
1.1 | 3.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.1 | 1.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.1 | 3.2 | GO:0015808 | L-alanine transport(GO:0015808) |
1.1 | 2.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
1.1 | 10.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
1.1 | 4.3 | GO:0035909 | aorta morphogenesis(GO:0035909) |
1.1 | 3.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.1 | 1.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.1 | 5.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.1 | 3.2 | GO:0043584 | nose development(GO:0043584) |
1.1 | 1.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
1.1 | 77.5 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
1.1 | 7.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.1 | 3.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.1 | 3.2 | GO:0042640 | anagen(GO:0042640) |
1.1 | 6.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.1 | 6.4 | GO:0003334 | keratinocyte development(GO:0003334) |
1.1 | 1.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.1 | 1.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.1 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 2.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
1.1 | 1.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.1 | 1.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.1 | 4.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
1.0 | 2.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 2.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
1.0 | 40.7 | GO:0032526 | response to retinoic acid(GO:0032526) |
1.0 | 3.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.0 | 5.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.0 | 2.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.0 | 2.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.0 | 1.0 | GO:0002526 | acute inflammatory response(GO:0002526) |
1.0 | 1.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.0 | 12.4 | GO:0001706 | endoderm formation(GO:0001706) |
1.0 | 9.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.0 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.0 | 4.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
1.0 | 4.1 | GO:0030163 | protein catabolic process(GO:0030163) |
1.0 | 2.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.0 | 18.5 | GO:0016925 | protein sumoylation(GO:0016925) |
1.0 | 5.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.0 | 6.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
1.0 | 8.2 | GO:0043248 | proteasome assembly(GO:0043248) |
1.0 | 2.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.0 | 8.1 | GO:0042311 | vasodilation(GO:0042311) |
1.0 | 3.1 | GO:0032835 | glomerulus development(GO:0032835) |
1.0 | 2.0 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
1.0 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.0 | 7.1 | GO:0031167 | rRNA methylation(GO:0031167) |
1.0 | 3.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.0 | 1.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.0 | 1.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.0 | 1.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
1.0 | 7.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.0 | 1.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.0 | 7.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.0 | 7.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.0 | 39.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
1.0 | 2.0 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.0 | 5.0 | GO:0019915 | lipid storage(GO:0019915) |
1.0 | 4.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.0 | 2.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
1.0 | 2.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.0 | 6.0 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.0 | 1.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
1.0 | 2.0 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
1.0 | 3.0 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
1.0 | 4.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
1.0 | 1.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.0 | 2.0 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
1.0 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.0 | 6.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
1.0 | 3.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.0 | 2.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.0 | 3.9 | GO:0031638 | zymogen activation(GO:0031638) |
1.0 | 1.0 | GO:1904872 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
1.0 | 16.7 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
1.0 | 2.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
1.0 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.0 | 2.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.0 | 2.9 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
1.0 | 2.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.0 | 1.0 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
1.0 | 2.0 | GO:0002215 | defense response to nematode(GO:0002215) |
1.0 | 6.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.0 | 7.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.0 | 1.0 | GO:0002339 | B cell selection(GO:0002339) |
1.0 | 1.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.0 | 3.9 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
1.0 | 1.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.0 | 3.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.0 | 4.8 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
1.0 | 1.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
1.0 | 10.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
1.0 | 1.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.0 | 1.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.0 | 1.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.0 | 3.8 | GO:0030539 | male genitalia development(GO:0030539) |
1.0 | 9.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
1.0 | 2.9 | GO:1901660 | calcium ion export(GO:1901660) |
1.0 | 7.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
1.0 | 10.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.0 | 1.0 | GO:0043383 | negative T cell selection(GO:0043383) |
1.0 | 5.7 | GO:0017144 | drug metabolic process(GO:0017144) |
1.0 | 1.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
1.0 | 3.8 | GO:0006907 | pinocytosis(GO:0006907) |
1.0 | 2.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.9 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 1.9 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.9 | 9.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.9 | 15.1 | GO:0008542 | visual learning(GO:0008542) |
0.9 | 4.7 | GO:0033280 | response to vitamin D(GO:0033280) |
0.9 | 1.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.9 | 6.6 | GO:0006862 | nucleotide transport(GO:0006862) purine nucleotide transport(GO:0015865) |
0.9 | 0.9 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.9 | 6.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.9 | 5.6 | GO:0043489 | RNA stabilization(GO:0043489) |
0.9 | 4.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.9 | 6.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.9 | 7.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.9 | 0.9 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.9 | 0.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.9 | 0.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.9 | 3.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.9 | 1.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 6.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.9 | 26.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.9 | 0.9 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.9 | 1.8 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.9 | 20.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.9 | 0.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.9 | 1.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.9 | 8.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.9 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 5.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.9 | 54.9 | GO:0016573 | histone acetylation(GO:0016573) |
0.9 | 2.7 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
0.9 | 2.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.9 | 0.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.9 | 99.3 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.9 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.9 | 2.7 | GO:0072678 | T cell migration(GO:0072678) |
0.9 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.9 | 2.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 5.4 | GO:0000910 | cytokinesis(GO:0000910) |
0.9 | 2.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.9 | 9.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.9 | 3.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.9 | 1.8 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
0.9 | 1.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.9 | 5.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.9 | 53.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.9 | 2.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.9 | 4.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.9 | 5.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.9 | 1.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.9 | 8.8 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.9 | 0.9 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.9 | 8.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.9 | 8.8 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
0.9 | 7.0 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.9 | 2.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.9 | 9.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.9 | 6.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.9 | 56.2 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.9 | 2.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.9 | 0.9 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.9 | 4.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.9 | 1.7 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.9 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.9 | 0.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 5.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.9 | 10.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.9 | 8.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.9 | 4.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.9 | 10.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.9 | 4.3 | GO:0001101 | response to acid chemical(GO:0001101) |
0.9 | 14.5 | GO:0051592 | response to calcium ion(GO:0051592) |
0.9 | 5.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.9 | 5.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.9 | 1.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.9 | 0.9 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.9 | 2.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.9 | 2.6 | GO:0036233 | glycine import(GO:0036233) |
0.8 | 6.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.8 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 4.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.8 | 1.7 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.8 | 11.0 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.8 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.8 | 6.7 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.8 | 5.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.8 | 2.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 1.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.8 | 2.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.8 | 0.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.8 | 2.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.8 | 15.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.8 | 2.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 1.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.8 | 1.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.8 | 0.8 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.8 | 1.6 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.8 | 5.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.8 | 28.5 | GO:0016485 | protein processing(GO:0016485) |
0.8 | 1.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.8 | 1.6 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.8 | 1.6 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.8 | 3.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.8 | 2.4 | GO:0007620 | copulation(GO:0007620) |
0.8 | 5.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.8 | 30.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.8 | 7.3 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.8 | 8.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.8 | 4.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.8 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.8 | 1.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.8 | 1.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.8 | 6.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 2.4 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.8 | 13.6 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.8 | 0.8 | GO:0010159 | specification of organ position(GO:0010159) |
0.8 | 1.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.8 | 1.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.8 | 0.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.8 | 11.9 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.8 | 2.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.8 | 3.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.8 | 1.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 12.5 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.8 | 1.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.8 | 1.6 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.8 | 2.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.8 | 30.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.8 | 1.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.8 | 4.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.8 | 2.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.8 | 66.0 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.8 | 0.8 | GO:0042755 | eating behavior(GO:0042755) |
0.8 | 3.1 | GO:0061458 | reproductive system development(GO:0061458) |
0.8 | 0.8 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.8 | 6.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.8 | 5.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.8 | 5.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.8 | 1.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.8 | 20.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.8 | 6.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.8 | 2.3 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.8 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 0.8 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.8 | 1.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.8 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.8 | 4.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 3.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.8 | 0.8 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.8 | 12.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.8 | 3.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.8 | 3.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.8 | 5.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 1.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.8 | 3.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.8 | 0.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.8 | 1.5 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.7 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 22.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.7 | 6.0 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.7 | 2.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 5.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.7 | 3.0 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.7 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.7 | 3.7 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.7 | 1.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.7 | 0.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 3.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 6.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.7 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.7 | 20.6 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.7 | 6.6 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.7 | 4.4 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.7 | 1.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.7 | 0.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.7 | 2.9 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.7 | 5.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.7 | 33.4 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.7 | 2.9 | GO:0042493 | response to drug(GO:0042493) |
0.7 | 0.7 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.7 | 1.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.7 | 2.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.7 | 11.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.7 | 5.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.7 | 4.3 | GO:0007584 | response to nutrient(GO:0007584) |
0.7 | 1.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.7 | 2.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.7 | 8.6 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.7 | 0.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.7 | 7.1 | GO:0007565 | female pregnancy(GO:0007565) |
0.7 | 2.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.7 | 10.6 | GO:0007281 | germ cell development(GO:0007281) |
0.7 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.7 | 13.4 | GO:0030100 | regulation of endocytosis(GO:0030100) |
0.7 | 4.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.7 | 7.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.7 | 1.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.7 | 2.8 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.7 | 2.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.7 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.7 | 2.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.7 | 0.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.7 | 4.9 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.7 | 0.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.7 | 2.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 4.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 11.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.7 | 4.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 0.7 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.7 | 0.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.7 | 2.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.7 | 1.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.7 | 6.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.7 | 2.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.7 | 0.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.7 | 1.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 2.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 1.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.7 | 3.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 0.7 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.7 | 1.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.7 | 2.7 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.7 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.7 | 0.7 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.7 | 2.0 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.7 | 6.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.7 | 0.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.7 | 0.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.7 | 1.3 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.7 | 4.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.7 | 0.7 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.7 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 8.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.7 | 0.7 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.7 | 5.9 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.7 | 0.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.7 | 7.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.7 | 2.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.7 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 8.5 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.7 | 3.3 | GO:0071229 | cellular response to acid chemical(GO:0071229) |
0.7 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.7 | 3.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.7 | 1.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.7 | 1.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.7 | 3.3 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.6 | 1.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.6 | 1.9 | GO:0007141 | male meiosis I(GO:0007141) |
0.6 | 1.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.6 | 1.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.6 | 103.0 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.6 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 5.1 | GO:0042745 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle(GO:0042745) |
0.6 | 1.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.6 | 2.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.6 | 2.6 | GO:0035883 | enteroendocrine cell differentiation(GO:0035883) |
0.6 | 2.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.6 | 2.5 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.6 | 1.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.6 | 1.9 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.6 | 7.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.6 | 6.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 7.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.6 | 4.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 0.6 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.6 | 0.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 1.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.6 | 3.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 0.6 | GO:0032944 | regulation of mononuclear cell proliferation(GO:0032944) |
0.6 | 1.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.6 | 0.6 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.6 | 1.9 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.6 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.6 | 1.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.6 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.6 | 2.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 3.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.6 | 1.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.6 | 0.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.6 | 2.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.6 | 0.6 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.6 | 1.2 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.6 | 1.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 0.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.6 | 1.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.8 | GO:0007492 | endoderm development(GO:0007492) |
0.6 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.6 | 2.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 2.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.6 | 81.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.6 | 0.6 | GO:0043276 | anoikis(GO:0043276) |
0.6 | 1.2 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.6 | 3.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.6 | 1.8 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.6 | 5.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.6 | 22.4 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.6 | 1.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.6 | 5.9 | GO:0070613 | regulation of protein processing(GO:0070613) regulation of protein maturation(GO:1903317) |
0.6 | 1.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 23.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.6 | 10.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.6 | 1.8 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.6 | 1.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.6 | 1.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.6 | 4.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.6 | 33.9 | GO:0007601 | visual perception(GO:0007601) |
0.6 | 1.2 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.6 | 1.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.6 | 13.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.6 | 1.2 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.6 | 2.9 | GO:0001825 | blastocyst formation(GO:0001825) |
0.6 | 5.2 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.6 | 0.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.6 | 2.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.6 | 0.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.6 | 1.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.6 | 10.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.6 | 2.3 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
0.6 | 13.6 | GO:0034440 | lipid oxidation(GO:0034440) |
0.6 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.6 | 2.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.6 | 6.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.6 | 1.7 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.6 | 2.2 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 2.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.6 | 1.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 1.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.6 | 1.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.6 | 2.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.6 | 0.6 | GO:0032635 | interleukin-6 production(GO:0032635) |
0.6 | 0.6 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.6 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 3.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 3.3 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
0.6 | 2.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.6 | 1.1 | GO:0034332 | adherens junction organization(GO:0034332) |
0.6 | 2.8 | GO:0035904 | aorta development(GO:0035904) |
0.6 | 1.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.6 | 1.1 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.6 | 2.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.5 | 30.1 | GO:0010876 | lipid localization(GO:0010876) |
0.5 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 1.6 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.5 | 1.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.5 | 3.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.5 | 1.1 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.5 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 0.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 2.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.5 | 79.9 | GO:0005975 | carbohydrate metabolic process(GO:0005975) |
0.5 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 2.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.5 | 2.6 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 2.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 15.7 | GO:0006821 | chloride transport(GO:0006821) |
0.5 | 1.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 4.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.5 | 3.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 1.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.5 | 1.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.5 | 29.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.5 | 1.5 | GO:0001759 | organ induction(GO:0001759) |
0.5 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 2.6 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
0.5 | 1.0 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.5 | 18.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.5 | 2.0 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.5 | 20.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.5 | 2.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.5 | 2.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 1.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 2.0 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.5 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 4.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.5 | 1.0 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 1.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 6.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.5 | 31.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.5 | 1.0 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.5 | 2.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.5 | 0.5 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.5 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.5 | 0.5 | GO:0060433 | bronchus development(GO:0060433) |
0.5 | 1.5 | GO:0055024 | regulation of cardiac muscle tissue development(GO:0055024) |
0.5 | 2.9 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.5 | 2.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.5 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.5 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.5 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 3.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.5 | 5.8 | GO:0050714 | positive regulation of protein secretion(GO:0050714) |
0.5 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.5 | 0.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.5 | 0.5 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.5 | 1.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.5 | 2.4 | GO:0071326 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) |
0.5 | 4.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.5 | 0.5 | GO:0000041 | transition metal ion transport(GO:0000041) |
0.5 | 1.9 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.5 | 2.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.5 | 0.5 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.5 | 4.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.5 | 2.3 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.5 | 0.5 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.5 | 0.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.5 | 1.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.5 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 4.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 0.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 0.5 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.5 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 1.4 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.5 | 1.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.3 | GO:0050718 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.4 | 1.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 2.7 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.4 | 0.9 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.4 | 4.0 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.4 | 7.0 | GO:0060402 | calcium ion transport into cytosol(GO:0060402) |
0.4 | 0.4 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.4 | 27.0 | GO:0009617 | response to bacterium(GO:0009617) |
0.4 | 1.3 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 33.8 | GO:0032259 | methylation(GO:0032259) |
0.4 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.4 | 34.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.4 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.4 | 76.4 | GO:0048232 | male gamete generation(GO:0048232) |
0.4 | 2.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.4 | 1.3 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.4 | 1.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.4 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 0.4 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.4 | 2.1 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.4 | 2.1 | GO:0009791 | post-embryonic development(GO:0009791) |
0.4 | 2.1 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.4 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 8.3 | GO:0031424 | keratinization(GO:0031424) |
0.4 | 19.0 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.4 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 0.4 | GO:0031935 | regulation of chromatin silencing(GO:0031935) positive regulation of chromatin silencing(GO:0031937) |
0.4 | 0.8 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.4 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.4 | 1.6 | GO:0045216 | cell-cell junction organization(GO:0045216) |
0.4 | 20.3 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.4 | 0.4 | GO:0060416 | response to growth hormone(GO:0060416) |
0.4 | 0.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.4 | 10.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.4 | 5.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.4 | 1.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 0.8 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.4 | 1.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.4 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 1.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 36.0 | GO:0098602 | single organism cell adhesion(GO:0098602) |
0.4 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.4 | 0.4 | GO:0006775 | fat-soluble vitamin metabolic process(GO:0006775) |
0.4 | 0.8 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.4 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 0.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.4 | 0.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 21.0 | GO:0006914 | autophagy(GO:0006914) |
0.4 | 0.4 | GO:0070663 | regulation of leukocyte proliferation(GO:0070663) |
0.4 | 2.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 0.4 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.4 | 0.4 | GO:0006766 | vitamin metabolic process(GO:0006766) |
0.4 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.4 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 2.3 | GO:0045137 | development of primary sexual characteristics(GO:0045137) |
0.4 | 0.4 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.4 | 3.3 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.4 | 3.7 | GO:0007051 | spindle organization(GO:0007051) |
0.4 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 2.6 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.4 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.4 | 4.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 4.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.4 | 0.4 | GO:1904064 | positive regulation of cation transmembrane transport(GO:1904064) |
0.4 | 1.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.4 | 0.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.4 | 1.1 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.4 | 0.4 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
0.4 | 0.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.4 | 0.7 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.4 | 0.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 0.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.4 | 1.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.4 | 1.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.3 | 4.9 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 1.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 4.2 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 0.3 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.3 | 3.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.3 | 1.4 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.3 | 1.7 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.3 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.3 | 0.3 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.3 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 2.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 2.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 0.3 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.3 | 0.3 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.3 | 1.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 12.7 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.3 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 2.9 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.3 | 0.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.3 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.3 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 4.8 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.3 | 1.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.6 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.3 | 0.3 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.3 | 6.8 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.3 | 0.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 2.8 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.3 | 1.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 0.9 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.3 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 2.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 11.0 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.3 | 0.3 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.3 | 8.6 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
0.3 | 0.3 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.3 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 3.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 1.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 3.6 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.3 | 2.8 | GO:0048278 | vesicle docking(GO:0048278) |
0.3 | 1.4 | GO:0051057 | positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.3 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 0.3 | GO:0050931 | pigment cell differentiation(GO:0050931) |
0.3 | 11.4 | GO:0055080 | cation homeostasis(GO:0055080) |
0.3 | 1.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.3 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 0.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 1.1 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.3 | 0.3 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.3 | 0.3 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.3 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 4.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.5 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.3 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.3 | GO:0051304 | chromosome separation(GO:0051304) |
0.3 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 0.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.3 | 1.3 | GO:0007276 | gamete generation(GO:0007276) |
0.3 | 0.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.3 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.2 | 10.2 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.2 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.5 | GO:0000279 | M phase(GO:0000279) |
0.2 | 1.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.2 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.2 | 5.5 | GO:0042113 | B cell activation(GO:0042113) |
0.2 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.2 | GO:0051048 | negative regulation of secretion(GO:0051048) |
0.2 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 3.9 | GO:0032271 | regulation of protein polymerization(GO:0032271) |
0.2 | 0.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.9 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.2 | 0.4 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.2 | 0.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 1.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.2 | 0.2 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.2 | 0.2 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.2 | GO:0002700 | regulation of production of molecular mediator of immune response(GO:0002700) |
0.2 | 0.2 | GO:0071709 | membrane assembly(GO:0071709) |
0.2 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 4.2 | GO:0009306 | protein secretion(GO:0009306) |
0.2 | 0.4 | GO:0051899 | membrane depolarization(GO:0051899) |
0.2 | 0.2 | GO:0009262 | deoxyribonucleotide metabolic process(GO:0009262) |
0.2 | 5.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 4.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 5.4 | GO:0003012 | muscle system process(GO:0003012) |
0.2 | 1.2 | GO:0060996 | dendritic spine development(GO:0060996) |
0.2 | 0.8 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.6 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.2 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.2 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.2 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.2 | 0.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 4.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 0.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.9 | GO:0009101 | glycoprotein biosynthetic process(GO:0009101) |
0.2 | 0.2 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
0.2 | 1.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 8.3 | GO:0006897 | endocytosis(GO:0006897) |
0.2 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 0.5 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.2 | 0.2 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.2 | 0.5 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.2 | 0.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.2 | 0.7 | GO:0046496 | nicotinamide nucleotide metabolic process(GO:0046496) |
0.2 | 0.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.2 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.2 | 0.2 | GO:1903524 | positive regulation of blood circulation(GO:1903524) |
0.2 | 0.2 | GO:0043687 | C-terminal protein amino acid modification(GO:0018410) C-terminal protein deglutamylation(GO:0035609) post-translational protein modification(GO:0043687) |
0.2 | 0.2 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.2 | 0.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.2 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
0.2 | 0.2 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.2 | 0.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.2 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.2 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.6 | GO:0007568 | aging(GO:0007568) |
0.2 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.2 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.4 | GO:0048167 | regulation of synaptic plasticity(GO:0048167) |
0.1 | 5.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 1.6 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.1 | 4.3 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0021587 | hindbrain morphogenesis(GO:0021575) cerebellum morphogenesis(GO:0021587) |
0.1 | 0.1 | GO:0030818 | negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 3.7 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.3 | GO:0008652 | cellular amino acid biosynthetic process(GO:0008652) |
0.1 | 11.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 1.3 | GO:0042552 | myelination(GO:0042552) |
0.1 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.1 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0002699 | positive regulation of immune effector process(GO:0002699) |
0.1 | 10.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.0 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.5 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.1 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.1 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
0.1 | 0.1 | GO:0002703 | regulation of leukocyte mediated immunity(GO:0002703) |
0.1 | 0.1 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.4 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 4.9 | GO:0006325 | chromatin organization(GO:0006325) |
0.1 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 13.4 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 17.5 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.4 | GO:0048545 | response to steroid hormone(GO:0048545) |
0.1 | 0.2 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.1 | 52.8 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.1 | GO:0009620 | response to fungus(GO:0009620) |
0.1 | 0.9 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.1 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.0 | 0.0 | GO:2000377 | regulation of reactive oxygen species metabolic process(GO:2000377) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.6 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0052547 | regulation of peptidase activity(GO:0052547) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0009064 | glutamine family amino acid metabolic process(GO:0009064) |
0.0 | 0.0 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0002793 | positive regulation of peptide secretion(GO:0002793) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 7.0 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.1 | GO:0050821 | protein stabilization(GO:0050821) |
0.0 | 0.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.3 | 117.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
14.5 | 57.9 | GO:1990357 | terminal web(GO:1990357) |
12.4 | 37.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
10.6 | 42.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
8.9 | 26.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
7.6 | 75.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
7.4 | 44.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
7.4 | 103.3 | GO:0031528 | microvillus membrane(GO:0031528) |
7.3 | 21.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
7.1 | 42.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
6.6 | 26.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
6.2 | 24.8 | GO:0030027 | lamellipodium(GO:0030027) |
6.1 | 36.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
6.1 | 24.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
6.0 | 30.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
5.9 | 29.5 | GO:0031983 | vesicle lumen(GO:0031983) |
5.9 | 46.9 | GO:0042627 | chylomicron(GO:0042627) |
5.7 | 5.7 | GO:0071203 | WASH complex(GO:0071203) |
5.6 | 38.9 | GO:0043219 | lateral loop(GO:0043219) |
5.4 | 27.2 | GO:0008091 | spectrin(GO:0008091) |
5.2 | 5.2 | GO:0046930 | pore complex(GO:0046930) |
5.1 | 40.6 | GO:0045179 | apical cortex(GO:0045179) |
5.0 | 10.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
4.9 | 14.7 | GO:0043293 | apoptosome(GO:0043293) |
4.8 | 28.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
4.7 | 543.5 | GO:0005903 | brush border(GO:0005903) |
4.7 | 37.7 | GO:0031209 | SCAR complex(GO:0031209) |
4.7 | 28.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
4.6 | 27.6 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
4.6 | 27.4 | GO:0005915 | zonula adherens(GO:0005915) |
4.6 | 18.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
4.4 | 22.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
4.4 | 8.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
4.4 | 17.7 | GO:0042827 | platelet dense granule(GO:0042827) |
4.3 | 13.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
4.2 | 12.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.2 | 16.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
4.1 | 32.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
4.0 | 80.2 | GO:0045120 | pronucleus(GO:0045120) |
4.0 | 36.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.9 | 19.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.8 | 3.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
3.8 | 26.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
3.8 | 19.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.8 | 19.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
3.8 | 15.1 | GO:1990246 | uniplex complex(GO:1990246) |
3.8 | 22.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
3.7 | 7.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.7 | 59.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
3.7 | 11.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
3.6 | 10.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
3.6 | 54.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
3.5 | 10.5 | GO:0005914 | spot adherens junction(GO:0005914) |
3.5 | 14.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
3.5 | 41.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
3.4 | 57.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
3.4 | 10.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
3.4 | 10.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
3.3 | 23.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.3 | 36.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
3.2 | 22.6 | GO:0097470 | ribbon synapse(GO:0097470) |
3.1 | 3.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.1 | 9.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.0 | 6.1 | GO:0005579 | membrane attack complex(GO:0005579) |
3.0 | 27.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
3.0 | 12.1 | GO:0000125 | PCAF complex(GO:0000125) |
3.0 | 9.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.9 | 5.9 | GO:0031512 | motile primary cilium(GO:0031512) |
2.9 | 20.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.9 | 5.8 | GO:0042599 | lamellar body(GO:0042599) |
2.9 | 14.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
2.9 | 22.9 | GO:0070652 | HAUS complex(GO:0070652) |
2.9 | 8.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
2.9 | 5.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.9 | 8.6 | GO:0005745 | m-AAA complex(GO:0005745) |
2.9 | 8.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
2.8 | 19.8 | GO:0071437 | invadopodium(GO:0071437) |
2.8 | 2.8 | GO:0031523 | Myb complex(GO:0031523) |
2.8 | 81.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.7 | 63.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.7 | 122.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.7 | 5.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.7 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.7 | 18.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
2.7 | 13.3 | GO:0044327 | dendritic spine head(GO:0044327) |
2.7 | 13.3 | GO:0030056 | hemidesmosome(GO:0030056) |
2.6 | 63.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
2.6 | 13.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.6 | 43.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
2.6 | 7.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
2.6 | 5.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.5 | 2.5 | GO:0034274 | extrinsic component of vacuolar membrane(GO:0000306) Atg12-Atg5-Atg16 complex(GO:0034274) |
2.5 | 5.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.5 | 108.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.5 | 59.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
2.5 | 22.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
2.5 | 9.8 | GO:1990130 | Iml1 complex(GO:1990130) |
2.4 | 7.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.4 | 7.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
2.4 | 9.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
2.4 | 4.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
2.4 | 9.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.4 | 9.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
2.4 | 26.3 | GO:0030914 | STAGA complex(GO:0030914) |
2.4 | 7.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.4 | 4.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
2.4 | 16.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.4 | 2.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
2.4 | 16.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
2.3 | 7.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
2.3 | 37.4 | GO:0000145 | exocyst(GO:0000145) |
2.3 | 27.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
2.3 | 120.8 | GO:0005811 | lipid particle(GO:0005811) |
2.3 | 13.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.3 | 9.2 | GO:0071439 | clathrin complex(GO:0071439) |
2.3 | 13.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
2.3 | 83.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
2.3 | 85.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
2.2 | 4.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.2 | 4.4 | GO:0030870 | Mre11 complex(GO:0030870) |
2.2 | 72.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
2.2 | 17.4 | GO:0000243 | commitment complex(GO:0000243) |
2.2 | 19.5 | GO:0032797 | SMN complex(GO:0032797) |
2.2 | 19.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.2 | 36.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
2.2 | 4.3 | GO:0030008 | TRAPP complex(GO:0030008) |
2.2 | 6.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
2.1 | 8.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.1 | 25.6 | GO:0097546 | ciliary base(GO:0097546) |
2.1 | 21.2 | GO:0008278 | cohesin complex(GO:0008278) |
2.1 | 2.1 | GO:0016342 | catenin complex(GO:0016342) |
2.1 | 23.2 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
2.1 | 16.8 | GO:0032982 | myosin filament(GO:0032982) |
2.1 | 16.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
2.1 | 6.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
2.1 | 6.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.1 | 103.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
2.1 | 8.3 | GO:0000938 | GARP complex(GO:0000938) |
2.1 | 18.6 | GO:0031143 | pseudopodium(GO:0031143) |
2.1 | 12.4 | GO:0012505 | endomembrane system(GO:0012505) |
2.1 | 8.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.0 | 2.0 | GO:1990423 | RZZ complex(GO:1990423) |
2.0 | 42.8 | GO:0051233 | spindle midzone(GO:0051233) |
2.0 | 10.2 | GO:0043203 | axon hillock(GO:0043203) |
2.0 | 8.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
2.0 | 131.2 | GO:0005938 | cell cortex(GO:0005938) |
2.0 | 6.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
2.0 | 8.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
2.0 | 30.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
2.0 | 8.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.0 | 95.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
2.0 | 2.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.0 | 51.6 | GO:0001772 | immunological synapse(GO:0001772) |
2.0 | 2.0 | GO:0000812 | Swr1 complex(GO:0000812) |
2.0 | 15.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.0 | 64.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.0 | 43.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
2.0 | 3.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.0 | 111.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.0 | 3.9 | GO:0016460 | myosin II complex(GO:0016460) |
2.0 | 33.2 | GO:0000242 | pericentriolar material(GO:0000242) |
1.9 | 7.8 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
1.9 | 48.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.9 | 28.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.9 | 7.6 | GO:0001652 | granular component(GO:0001652) |
1.9 | 26.7 | GO:0005876 | spindle microtubule(GO:0005876) |
1.9 | 7.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.9 | 130.9 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.9 | 5.7 | GO:0048179 | activin receptor complex(GO:0048179) |
1.9 | 78.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.9 | 82.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.9 | 5.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.9 | 204.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.8 | 20.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.8 | 20.0 | GO:0000346 | transcription export complex(GO:0000346) |
1.8 | 9.0 | GO:0033503 | HULC complex(GO:0033503) |
1.8 | 5.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.8 | 8.9 | GO:0033270 | paranode region of axon(GO:0033270) |
1.8 | 10.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.7 | 7.0 | GO:0044194 | cytolytic granule(GO:0044194) |
1.7 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.7 | 5.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.7 | 145.9 | GO:0072562 | blood microparticle(GO:0072562) |
1.7 | 5.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.7 | 24.2 | GO:0043196 | varicosity(GO:0043196) |
1.7 | 10.3 | GO:0070847 | core mediator complex(GO:0070847) |
1.7 | 5.2 | GO:0016600 | flotillin complex(GO:0016600) |
1.7 | 5.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.7 | 53.4 | GO:0031201 | SNARE complex(GO:0031201) |
1.7 | 5.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.7 | 6.8 | GO:0000805 | X chromosome(GO:0000805) |
1.7 | 23.8 | GO:0005902 | microvillus(GO:0005902) |
1.7 | 11.8 | GO:0000791 | euchromatin(GO:0000791) |
1.7 | 16.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.7 | 5.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.7 | 11.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.7 | 26.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
1.7 | 6.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.7 | 83.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.7 | 8.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.7 | 21.5 | GO:0038201 | TOR complex(GO:0038201) |
1.7 | 5.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.6 | 9.9 | GO:0042581 | specific granule(GO:0042581) |
1.6 | 9.8 | GO:0005776 | autophagosome(GO:0005776) |
1.6 | 85.0 | GO:0000922 | spindle pole(GO:0000922) |
1.6 | 4.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.6 | 11.4 | GO:0032426 | stereocilium tip(GO:0032426) |
1.6 | 17.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.6 | 1.6 | GO:0097413 | Lewy body(GO:0097413) |
1.6 | 19.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.6 | 109.0 | GO:0005769 | early endosome(GO:0005769) |
1.6 | 52.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.6 | 68.5 | GO:0005871 | kinesin complex(GO:0005871) |
1.6 | 6.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.6 | 1.6 | GO:0042583 | chromaffin granule(GO:0042583) |
1.6 | 11.0 | GO:0005795 | Golgi stack(GO:0005795) |
1.6 | 6.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.6 | 96.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.5 | 4.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 12.4 | GO:0045178 | basal part of cell(GO:0045178) |
1.5 | 4.6 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
1.5 | 1.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 4.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.5 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
1.5 | 7.6 | GO:0061702 | inflammasome complex(GO:0061702) |
1.5 | 4.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.5 | 4.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.5 | 13.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
1.5 | 4.5 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
1.5 | 3.0 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 7.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.5 | 7.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.5 | 4.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.5 | 9.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.5 | 4.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.5 | 4.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.5 | 16.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.5 | 10.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.5 | 13.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.5 | 10.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.5 | 4.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.5 | 10.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.5 | 14.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.5 | 20.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.5 | 10.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.5 | 4.4 | GO:0031417 | NatC complex(GO:0031417) |
1.5 | 2751.8 | GO:0070062 | extracellular exosome(GO:0070062) |
1.5 | 19.0 | GO:0033391 | chromatoid body(GO:0033391) |
1.4 | 2.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 14.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.4 | 7.1 | GO:0005687 | U4 snRNP(GO:0005687) |
1.4 | 8.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.4 | 2.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.4 | 12.8 | GO:0032587 | ruffle membrane(GO:0032587) |
1.4 | 2.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.4 | 39.6 | GO:0005884 | actin filament(GO:0005884) |
1.4 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.4 | 4.2 | GO:0060091 | kinocilium(GO:0060091) |
1.4 | 1.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.4 | 1.4 | GO:1903349 | omegasome membrane(GO:1903349) |
1.4 | 25.0 | GO:0030658 | transport vesicle membrane(GO:0030658) |
1.4 | 41.7 | GO:0016363 | nuclear matrix(GO:0016363) |
1.4 | 94.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.4 | 26.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.4 | 2.8 | GO:0055087 | Ski complex(GO:0055087) |
1.4 | 19.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.4 | 19.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.4 | 5.5 | GO:0035363 | histone locus body(GO:0035363) |
1.4 | 10.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.4 | 21.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
1.4 | 5.4 | GO:0071797 | LUBAC complex(GO:0071797) |
1.3 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.3 | 2.7 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 25.3 | GO:0016235 | aggresome(GO:0016235) |
1.3 | 6.6 | GO:0042587 | glycogen granule(GO:0042587) |
1.3 | 18.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.3 | 2.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.3 | 2.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.3 | 1.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.3 | 9.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.3 | 3.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.3 | 6.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.3 | 25.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.3 | 3.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.3 | 5.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.3 | 47.9 | GO:0005623 | cell(GO:0005623) |
1.3 | 3.8 | GO:0042588 | zymogen granule(GO:0042588) |
1.2 | 6.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.2 | 3.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.2 | 43.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.2 | 5.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.2 | 54.5 | GO:0016605 | PML body(GO:0016605) |
1.2 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.2 | 19.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.2 | 190.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.2 | 2.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.2 | 7.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.2 | 2.4 | GO:0000802 | transverse filament(GO:0000802) |
1.2 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
1.2 | 1.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.2 | 6.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.2 | 1.2 | GO:1904949 | ATPase complex(GO:1904949) |
1.2 | 15.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.2 | 14.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.2 | 1.2 | GO:0042641 | actomyosin(GO:0042641) |
1.2 | 2.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.2 | 44.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
1.2 | 3.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.2 | 8.1 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 118.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.2 | 720.8 | GO:0005829 | cytosol(GO:0005829) |
1.1 | 2.3 | GO:0071547 | piP-body(GO:0071547) |
1.1 | 39.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.1 | 2.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.1 | 2.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.1 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
1.1 | 6.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.1 | 12.3 | GO:0071565 | nBAF complex(GO:0071565) |
1.1 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 3.3 | GO:0031090 | organelle membrane(GO:0031090) |
1.1 | 2.2 | GO:0098858 | actin-based cell projection(GO:0098858) |
1.1 | 40.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.1 | 4.4 | GO:0072487 | MSL complex(GO:0072487) |
1.1 | 13.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
1.1 | 3.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.1 | 8.7 | GO:0000502 | proteasome complex(GO:0000502) |
1.1 | 40.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.1 | 40.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.1 | 11.9 | GO:0005771 | multivesicular body(GO:0005771) |
1.1 | 1.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.1 | 48.3 | GO:0030018 | Z disc(GO:0030018) |
1.1 | 26.6 | GO:0005819 | spindle(GO:0005819) |
1.1 | 82.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.1 | 6.4 | GO:0000801 | central element(GO:0000801) |
1.1 | 21.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
1.1 | 6.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 4.2 | GO:0032021 | NELF complex(GO:0032021) |
1.0 | 5.2 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 17.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
1.0 | 13.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.0 | 662.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
1.0 | 11.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.0 | 8.2 | GO:0036157 | outer dynein arm(GO:0036157) |
1.0 | 16.4 | GO:0030686 | 90S preribosome(GO:0030686) |
1.0 | 12.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.0 | 8.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.0 | 11.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.0 | 4.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.0 | 3.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.0 | 12.7 | GO:0030496 | midbody(GO:0030496) |
1.0 | 44.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.0 | 2.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.0 | 7.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.0 | 14.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.0 | 24.9 | GO:0016592 | mediator complex(GO:0016592) |
1.0 | 3.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.0 | 75.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.9 | 2.8 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 4.7 | GO:0012506 | vesicle membrane(GO:0012506) |
0.9 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.9 | 2.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 10.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.9 | 11.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.9 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.9 | 72.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.9 | 3.6 | GO:0002177 | manchette(GO:0002177) |
0.9 | 1.8 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.9 | 4.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.9 | 610.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.9 | 10.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.9 | 133.1 | GO:0031982 | vesicle(GO:0031982) |
0.9 | 1.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 5.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 2.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.9 | 11.4 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) protein kinase complex(GO:1902911) |
0.9 | 3.5 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 1.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.9 | 0.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.9 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.8 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.8 | 687.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.8 | 10.9 | GO:0030175 | filopodium(GO:0030175) |
0.8 | 259.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.8 | 67.3 | GO:0030141 | secretory granule(GO:0030141) |
0.8 | 66.4 | GO:0005768 | endosome(GO:0005768) |
0.8 | 15.5 | GO:0045095 | keratin filament(GO:0045095) |
0.8 | 3.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.8 | 31.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.8 | 11.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.8 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.8 | 3.1 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 3.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.8 | 1.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.8 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 1.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.8 | 5.3 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 2.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 6.4 | GO:0000786 | nucleosome(GO:0000786) |
0.7 | 2491.8 | GO:0005622 | intracellular(GO:0005622) |
0.7 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.7 | 3.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 4.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.7 | 2.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.7 | 2.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.7 | 0.7 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.6 | 55.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.6 | 2.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 546.8 | GO:0005576 | extracellular region(GO:0005576) |
0.6 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.5 | 1471.6 | GO:0016020 | membrane(GO:0016020) |
0.3 | 3.4 | GO:0043234 | protein complex(GO:0043234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.2 | 81.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
20.1 | 60.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
19.4 | 77.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
18.2 | 54.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
15.9 | 47.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
15.6 | 31.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
11.7 | 35.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
11.3 | 33.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
11.1 | 33.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
10.5 | 31.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
9.4 | 56.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
8.7 | 35.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
8.7 | 60.8 | GO:0018641 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
8.7 | 34.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
8.4 | 42.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
8.2 | 40.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
8.0 | 8.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
8.0 | 31.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
7.6 | 30.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
7.4 | 22.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
7.4 | 7.4 | GO:0015665 | choline transmembrane transporter activity(GO:0015220) alcohol transmembrane transporter activity(GO:0015665) |
7.3 | 43.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
7.2 | 21.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
7.2 | 28.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
7.1 | 21.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
7.0 | 28.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
7.0 | 14.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
6.8 | 20.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
6.8 | 34.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
6.8 | 54.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
6.7 | 20.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
6.7 | 47.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
6.7 | 33.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
6.7 | 20.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
6.7 | 33.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
6.6 | 39.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
6.5 | 19.4 | GO:0004103 | choline kinase activity(GO:0004103) |
6.3 | 6.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
6.3 | 18.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
6.3 | 25.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
6.1 | 36.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
6.0 | 18.0 | GO:0034618 | arginine binding(GO:0034618) |
6.0 | 24.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
5.9 | 23.7 | GO:0015232 | heme transporter activity(GO:0015232) |
5.9 | 5.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
5.9 | 11.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
5.9 | 17.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
5.9 | 29.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
5.9 | 23.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
5.8 | 17.5 | GO:1990188 | euchromatin binding(GO:1990188) |
5.8 | 34.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
5.7 | 17.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
5.7 | 45.6 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
5.5 | 22.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
5.4 | 54.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
5.4 | 81.2 | GO:0030955 | potassium ion binding(GO:0030955) |
5.4 | 16.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
5.4 | 26.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
5.4 | 5.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
5.3 | 31.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
5.3 | 21.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.3 | 26.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
5.2 | 15.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
5.2 | 20.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
5.1 | 25.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
5.1 | 20.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
5.1 | 40.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
5.0 | 24.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
5.0 | 5.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
5.0 | 5.0 | GO:0089720 | caspase binding(GO:0089720) |
5.0 | 24.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
4.9 | 29.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
4.9 | 64.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
4.9 | 19.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
4.8 | 14.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
4.8 | 19.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.8 | 19.2 | GO:0042731 | PH domain binding(GO:0042731) |
4.8 | 14.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
4.8 | 14.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
4.8 | 19.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
4.8 | 14.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.8 | 19.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
4.7 | 23.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
4.7 | 14.1 | GO:0019862 | IgA binding(GO:0019862) |
4.6 | 4.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
4.6 | 9.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
4.6 | 64.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
4.6 | 22.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
4.6 | 64.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
4.6 | 22.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
4.5 | 4.5 | GO:0015250 | water channel activity(GO:0015250) |
4.5 | 13.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
4.5 | 13.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
4.4 | 8.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
4.4 | 13.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.4 | 39.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
4.4 | 13.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
4.3 | 13.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
4.3 | 12.9 | GO:0055100 | adiponectin binding(GO:0055100) |
4.3 | 25.7 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
4.3 | 51.4 | GO:0016918 | retinal binding(GO:0016918) |
4.3 | 17.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
4.3 | 93.7 | GO:0008483 | transaminase activity(GO:0008483) |
4.2 | 38.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
4.2 | 12.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
4.2 | 33.6 | GO:0034046 | poly(G) binding(GO:0034046) |
4.2 | 12.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
4.1 | 20.3 | GO:0005499 | vitamin D binding(GO:0005499) |
4.1 | 16.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
4.0 | 16.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
4.0 | 4.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
4.0 | 24.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
4.0 | 4.0 | GO:0051287 | NAD binding(GO:0051287) |
4.0 | 15.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
4.0 | 23.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
4.0 | 7.9 | GO:0008199 | ferric iron binding(GO:0008199) |
4.0 | 11.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
3.9 | 23.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.9 | 3.9 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
3.9 | 50.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
3.9 | 111.9 | GO:0070330 | aromatase activity(GO:0070330) |
3.8 | 19.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
3.8 | 19.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.8 | 15.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
3.8 | 11.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.8 | 33.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
3.8 | 64.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
3.8 | 26.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
3.8 | 26.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.7 | 11.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.7 | 11.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
3.7 | 7.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
3.7 | 22.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
3.7 | 29.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.7 | 40.2 | GO:0043798 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
3.6 | 3.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
3.6 | 123.4 | GO:0042805 | actinin binding(GO:0042805) |
3.6 | 10.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
3.6 | 10.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
3.6 | 114.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
3.5 | 28.2 | GO:0051400 | BH domain binding(GO:0051400) |
3.5 | 10.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
3.5 | 10.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.5 | 10.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
3.5 | 17.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
3.5 | 17.5 | GO:0017040 | ceramidase activity(GO:0017040) |
3.5 | 3.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
3.5 | 24.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
3.5 | 17.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
3.5 | 10.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
3.4 | 6.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
3.4 | 10.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
3.4 | 109.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
3.4 | 10.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
3.4 | 27.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
3.4 | 10.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.4 | 23.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
3.4 | 3.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
3.4 | 23.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
3.4 | 3.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
3.3 | 10.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.3 | 23.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
3.3 | 89.8 | GO:0015485 | cholesterol binding(GO:0015485) |
3.3 | 23.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.3 | 9.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
3.3 | 9.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.3 | 16.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
3.3 | 13.1 | GO:0002054 | nucleobase binding(GO:0002054) |
3.3 | 9.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
3.3 | 3.3 | GO:0015927 | trehalase activity(GO:0015927) |
3.3 | 32.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
3.3 | 3.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
3.2 | 9.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
3.1 | 9.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.1 | 15.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
3.1 | 9.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.1 | 12.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
3.1 | 3.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
3.1 | 15.4 | GO:0071253 | connexin binding(GO:0071253) |
3.1 | 12.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.1 | 18.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.1 | 49.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
3.0 | 33.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
3.0 | 3.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
3.0 | 18.0 | GO:0005536 | glucose binding(GO:0005536) |
3.0 | 8.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
3.0 | 5.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
3.0 | 8.9 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
3.0 | 17.7 | GO:0015266 | protein channel activity(GO:0015266) |
3.0 | 20.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.9 | 20.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.9 | 5.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.9 | 14.7 | GO:0070728 | leucine binding(GO:0070728) |
2.9 | 11.7 | GO:0046790 | virion binding(GO:0046790) |
2.9 | 38.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
2.9 | 8.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.9 | 61.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.9 | 37.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.9 | 17.5 | GO:0005113 | patched binding(GO:0005113) |
2.9 | 23.3 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
2.9 | 87.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.9 | 8.7 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.9 | 26.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.9 | 34.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
2.9 | 43.0 | GO:0043274 | phospholipase binding(GO:0043274) |
2.9 | 8.6 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
2.8 | 2.8 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
2.8 | 45.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.8 | 8.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.8 | 11.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.8 | 5.6 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
2.8 | 28.1 | GO:0031005 | filamin binding(GO:0031005) |
2.8 | 2.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.8 | 11.2 | GO:0050693 | LBD domain binding(GO:0050693) |
2.8 | 14.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.8 | 2.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.8 | 72.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
2.8 | 5.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
2.8 | 13.9 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
2.8 | 16.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
2.8 | 13.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.8 | 5.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.7 | 8.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.7 | 11.0 | GO:0035671 | enone reductase activity(GO:0035671) |
2.7 | 16.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
2.7 | 16.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.7 | 8.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.7 | 13.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.7 | 59.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.7 | 40.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
2.7 | 2.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.7 | 2.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.7 | 13.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.7 | 2.7 | GO:0032183 | SUMO binding(GO:0032183) |
2.7 | 8.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.7 | 8.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
2.7 | 8.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.7 | 10.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.6 | 15.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.6 | 10.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.6 | 15.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
2.6 | 5.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.6 | 18.2 | GO:0046983 | protein dimerization activity(GO:0046983) |
2.6 | 18.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
2.6 | 7.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.6 | 7.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.6 | 7.8 | GO:0015288 | porin activity(GO:0015288) |
2.6 | 7.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.6 | 7.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
2.6 | 12.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
2.6 | 5.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.6 | 7.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.6 | 20.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.5 | 20.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.5 | 2.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
2.5 | 12.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.5 | 5.1 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
2.5 | 10.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.5 | 7.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.5 | 5.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.5 | 15.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.5 | 27.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
2.5 | 12.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.5 | 7.5 | GO:0031996 | thioesterase binding(GO:0031996) |
2.5 | 17.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.5 | 114.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
2.5 | 4.9 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
2.5 | 34.6 | GO:0005123 | death receptor binding(GO:0005123) |
2.5 | 14.8 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
2.5 | 7.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.5 | 7.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.5 | 22.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
2.5 | 7.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
2.5 | 9.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
2.5 | 137.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
2.4 | 4.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
2.4 | 7.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.4 | 7.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
2.4 | 14.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.4 | 9.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
2.4 | 70.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
2.4 | 7.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
2.4 | 67.9 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
2.4 | 45.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
2.4 | 26.4 | GO:0008061 | chitin binding(GO:0008061) |
2.4 | 4.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.4 | 7.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.4 | 19.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
2.4 | 26.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.4 | 14.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
2.4 | 47.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
2.4 | 78.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
2.4 | 14.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.4 | 26.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.4 | 33.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
2.4 | 44.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
2.4 | 9.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.4 | 25.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
2.4 | 7.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
2.3 | 9.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.3 | 9.4 | GO:0000182 | rDNA binding(GO:0000182) |
2.3 | 67.9 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
2.3 | 9.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
2.3 | 7.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.3 | 4.6 | GO:0030984 | kininogen binding(GO:0030984) |
2.3 | 9.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.3 | 6.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.3 | 2.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
2.3 | 13.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.3 | 9.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.3 | 13.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
2.3 | 6.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.3 | 2.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.3 | 11.4 | GO:0016936 | galactoside binding(GO:0016936) |
2.3 | 2.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
2.3 | 9.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
2.3 | 20.3 | GO:0031386 | protein tag(GO:0031386) |
2.3 | 6.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.2 | 15.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.2 | 13.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.2 | 8.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
2.2 | 6.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
2.2 | 19.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
2.2 | 6.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.2 | 19.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.2 | 105.0 | GO:0005518 | collagen binding(GO:0005518) |
2.2 | 13.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
2.2 | 4.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
2.2 | 6.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.2 | 6.5 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
2.2 | 8.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.2 | 6.5 | GO:0038132 | neuregulin binding(GO:0038132) |
2.1 | 8.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
2.1 | 6.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.1 | 6.4 | GO:0016531 | copper chaperone activity(GO:0016531) |
2.1 | 6.4 | GO:0008430 | selenium binding(GO:0008430) |
2.1 | 12.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.1 | 10.6 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
2.1 | 221.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.1 | 6.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.1 | 6.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.0 | 6.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.0 | 6.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.0 | 6.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
2.0 | 6.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.0 | 8.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
2.0 | 8.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.0 | 6.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.0 | 10.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.0 | 26.3 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
2.0 | 52.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
2.0 | 2.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.0 | 22.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.0 | 8.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
2.0 | 27.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
2.0 | 9.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
2.0 | 9.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.0 | 23.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
2.0 | 33.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.0 | 11.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.0 | 13.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
2.0 | 2.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.9 | 3.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
1.9 | 11.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.9 | 5.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.9 | 3.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.9 | 7.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.9 | 211.2 | GO:0003774 | motor activity(GO:0003774) |
1.9 | 5.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.9 | 19.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.9 | 13.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.9 | 5.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.9 | 15.2 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
1.9 | 1.9 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
1.9 | 91.3 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
1.9 | 15.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.9 | 28.1 | GO:0030506 | ankyrin binding(GO:0030506) |
1.9 | 13.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.9 | 16.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.9 | 5.6 | GO:0004359 | glutaminase activity(GO:0004359) |
1.9 | 20.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
1.9 | 1.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.9 | 11.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.9 | 44.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.9 | 66.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.8 | 14.8 | GO:0070403 | NAD+ binding(GO:0070403) |
1.8 | 3.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.8 | 16.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.8 | 7.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.8 | 5.5 | GO:0070061 | fructose binding(GO:0070061) |
1.8 | 1.8 | GO:0043199 | sulfate binding(GO:0043199) |
1.8 | 34.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.8 | 52.6 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
1.8 | 12.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.8 | 14.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.8 | 30.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.8 | 9.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.8 | 12.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.8 | 21.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.8 | 8.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.8 | 5.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
1.8 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.8 | 3.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.8 | 8.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.7 | 64.7 | GO:0030276 | clathrin binding(GO:0030276) |
1.7 | 8.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.7 | 29.7 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
1.7 | 5.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.7 | 5.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.7 | 19.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.7 | 71.4 | GO:0051117 | ATPase binding(GO:0051117) |
1.7 | 8.7 | GO:0031432 | titin binding(GO:0031432) |
1.7 | 3.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.7 | 3.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.7 | 3.5 | GO:0030332 | cyclin binding(GO:0030332) |
1.7 | 56.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.7 | 39.4 | GO:0005507 | copper ion binding(GO:0005507) |
1.7 | 3.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.7 | 5.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.7 | 20.1 | GO:0008143 | poly(A) binding(GO:0008143) |
1.7 | 1.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
1.7 | 1.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.7 | 15.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.7 | 16.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.7 | 15.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.7 | 6.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.7 | 33.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.7 | 33.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.7 | 6.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.7 | 3.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.7 | 5.0 | GO:2001069 | glycogen binding(GO:2001069) |
1.6 | 21.4 | GO:0015928 | fucosidase activity(GO:0015928) |
1.6 | 26.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.6 | 6.6 | GO:0034452 | dynactin binding(GO:0034452) |
1.6 | 4.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.6 | 16.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.6 | 3.3 | GO:0019002 | GMP binding(GO:0019002) |
1.6 | 1.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.6 | 26.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
1.6 | 4.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.6 | 13.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.6 | 6.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.6 | 8.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.6 | 13.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.6 | 21.1 | GO:0030515 | snoRNA binding(GO:0030515) |
1.6 | 6.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
1.6 | 1.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.6 | 11.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.6 | 1.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.6 | 6.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
1.6 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.6 | 150.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.6 | 1.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.6 | 38.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.6 | 4.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.6 | 6.4 | GO:0038100 | nodal binding(GO:0038100) |
1.6 | 17.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
1.6 | 1.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.6 | 43.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.6 | 4.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.6 | 29.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.6 | 4.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.6 | 6.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.6 | 4.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.6 | 3.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.6 | 29.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.5 | 41.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
1.5 | 3.1 | GO:0005319 | lipid transporter activity(GO:0005319) |
1.5 | 19.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.5 | 9.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.5 | 42.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
1.5 | 3.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.5 | 6.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.5 | 4.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.5 | 4.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.5 | 4.5 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
1.5 | 1.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
1.5 | 46.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.5 | 31.4 | GO:0019894 | kinesin binding(GO:0019894) |
1.5 | 6.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.5 | 7.5 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.5 | 16.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.5 | 26.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
1.5 | 6.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.5 | 5.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.5 | 5.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.5 | 4.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.5 | 14.8 | GO:0005542 | folic acid binding(GO:0005542) |
1.5 | 7.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.5 | 50.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.5 | 11.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.5 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.5 | 55.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.5 | 4.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.5 | 2.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.5 | 8.8 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.5 | 70.2 | GO:0019003 | GDP binding(GO:0019003) |
1.5 | 16.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.5 | 11.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.5 | 10.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.5 | 2.9 | GO:0070402 | NADPH binding(GO:0070402) |
1.5 | 17.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.4 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.4 | 7.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.4 | 39.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.4 | 1.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.4 | 4.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.4 | 18.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.4 | 22.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.4 | 7.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.4 | 1.4 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
1.4 | 2.9 | GO:0032451 | demethylase activity(GO:0032451) |
1.4 | 10.0 | GO:0045296 | cadherin binding(GO:0045296) |
1.4 | 5.7 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
1.4 | 4.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.4 | 2.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.4 | 2.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.4 | 2.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.4 | 21.1 | GO:0030507 | spectrin binding(GO:0030507) |
1.4 | 128.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.4 | 4.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.4 | 2.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.4 | 16.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.4 | 19.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.4 | 8.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.4 | 39.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.4 | 9.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.4 | 11.0 | GO:0033558 | protein deacetylase activity(GO:0033558) |
1.4 | 1.4 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.4 | 6.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.4 | 2.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.4 | 2.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.4 | 4.1 | GO:0015643 | toxic substance binding(GO:0015643) |
1.4 | 12.2 | GO:0048185 | activin binding(GO:0048185) |
1.4 | 2.7 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 19.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
1.4 | 5.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.4 | 1.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.4 | 10.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.3 | 6.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
1.3 | 5.4 | GO:0046914 | transition metal ion binding(GO:0046914) |
1.3 | 10.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.3 | 16.1 | GO:0002039 | p53 binding(GO:0002039) |
1.3 | 2.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.3 | 50.8 | GO:0000149 | SNARE binding(GO:0000149) |
1.3 | 1.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.3 | 20.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.3 | 85.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.3 | 15.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.3 | 2.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.3 | 22.4 | GO:0005504 | fatty acid binding(GO:0005504) |
1.3 | 7.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.3 | 6.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.3 | 3.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.3 | 3.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.3 | 13.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
1.3 | 3.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 2.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.3 | 2.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
1.3 | 1.3 | GO:0016151 | nickel cation binding(GO:0016151) |
1.3 | 14.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.3 | 15.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.3 | 5.2 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
1.3 | 1.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
1.3 | 2.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.3 | 7.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 5.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.3 | 2.5 | GO:0015926 | glucosidase activity(GO:0015926) |
1.3 | 8.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.3 | 8.8 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 5.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.3 | 5.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
1.3 | 2.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 3.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.2 | 2.5 | GO:0032190 | acrosin binding(GO:0032190) |
1.2 | 64.4 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
1.2 | 6.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.2 | 12.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
1.2 | 3.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.2 | 1.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.2 | 29.6 | GO:0004527 | exonuclease activity(GO:0004527) |
1.2 | 2.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.2 | 2.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.2 | 23.3 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
1.2 | 6.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.2 | 4.9 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
1.2 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
1.2 | 48.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
1.2 | 3.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.2 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.2 | 21.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
1.2 | 1.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.2 | 4.8 | GO:0044548 | S100 protein binding(GO:0044548) |
1.2 | 7.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.2 | 7.1 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.2 | 2.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.2 | 7.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.2 | 14.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.2 | 10.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.2 | 4.7 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
1.2 | 17.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.2 | 14.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
1.2 | 124.0 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
1.2 | 9.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.2 | 2.3 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
1.2 | 4.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.2 | 3.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.2 | 10.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
1.2 | 5.8 | GO:0000339 | RNA cap binding(GO:0000339) |
1.2 | 1.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.2 | 67.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
1.1 | 5.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.1 | 15.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.1 | 7.9 | GO:0000150 | recombinase activity(GO:0000150) |
1.1 | 16.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.1 | 14.6 | GO:0004497 | monooxygenase activity(GO:0004497) |
1.1 | 5.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.1 | 40.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.1 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.1 | 2.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.1 | 5.6 | GO:0050733 | RS domain binding(GO:0050733) |
1.1 | 113.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
1.1 | 4.4 | GO:0030371 | translation repressor activity(GO:0030371) |
1.1 | 8.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.1 | 4.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 3.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.1 | 3.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.1 | 2.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
1.1 | 9.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.1 | 2.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.1 | 1.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.1 | 69.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.1 | 3.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.1 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.1 | 2.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.1 | 236.8 | GO:0005525 | GTP binding(GO:0005525) |
1.1 | 3.2 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
1.1 | 20.4 | GO:0070888 | E-box binding(GO:0070888) |
1.1 | 1.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.1 | 9.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.1 | 20.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.1 | 10.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.1 | 2.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 20.1 | GO:0043621 | protein self-association(GO:0043621) |
1.1 | 1.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.1 | 7.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.1 | 4.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.1 | 2.1 | GO:0097016 | L27 domain binding(GO:0097016) |
1.0 | 2.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.0 | 2.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.0 | 2.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 1.0 | GO:0072349 | thyroid hormone transmembrane transporter activity(GO:0015349) modified amino acid transmembrane transporter activity(GO:0072349) |
1.0 | 71.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
1.0 | 5.2 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.0 | 10.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.0 | 18.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.0 | 9.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.0 | 3.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 115.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.0 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.0 | 214.4 | GO:0003779 | actin binding(GO:0003779) |
1.0 | 2.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.0 | 4.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 5.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.0 | 18.3 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
1.0 | 20.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 7.1 | GO:0001618 | virus receptor activity(GO:0001618) |
1.0 | 15.2 | GO:0005506 | iron ion binding(GO:0005506) |
1.0 | 54.5 | GO:0003823 | antigen binding(GO:0003823) |
1.0 | 6.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.0 | 133.2 | GO:0008134 | transcription factor binding(GO:0008134) |
1.0 | 2.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.0 | 5.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.0 | 6.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.0 | 10.9 | GO:0045502 | dynein binding(GO:0045502) |
1.0 | 84.2 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
1.0 | 3.0 | GO:1990405 | protein antigen binding(GO:1990405) |
1.0 | 4.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
1.0 | 16.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.0 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.0 | 77.9 | GO:0042393 | histone binding(GO:0042393) |
1.0 | 4.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.0 | 74.7 | GO:0051020 | GTPase binding(GO:0051020) |
1.0 | 4.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 10.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.0 | 9.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.0 | 17.5 | GO:0020037 | heme binding(GO:0020037) |
1.0 | 2.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 4.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.0 | 14.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
1.0 | 16.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.0 | 1.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
1.0 | 17.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.0 | 8.6 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.9 | 0.9 | GO:0016595 | glutamate binding(GO:0016595) |
0.9 | 2.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.9 | 2.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 2.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.9 | 13.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.9 | 24.3 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.9 | 9.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.9 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.9 | 55.6 | GO:0015293 | symporter activity(GO:0015293) |
0.9 | 0.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.9 | 12.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.9 | 7.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.9 | 3.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 13.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.9 | 1.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.9 | 4.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.9 | 3.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.9 | 4.5 | GO:0005521 | lamin binding(GO:0005521) |
0.9 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.9 | 3.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.9 | 154.8 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.9 | 1.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.9 | 13.1 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.9 | 119.2 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.9 | 1.7 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.9 | 41.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.9 | 2.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.9 | 5.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.9 | 2.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.9 | 6.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.8 | 50.1 | GO:0008289 | lipid binding(GO:0008289) |
0.8 | 7.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.8 | 2.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 5.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.8 | 17.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.8 | 3.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.8 | 1.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.8 | 4.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.8 | 1.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 13.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.8 | 14.8 | GO:0002020 | protease binding(GO:0002020) |
0.8 | 9.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.8 | 0.8 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.8 | 2.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 18.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.8 | 2.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 1.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.8 | 25.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.8 | 3.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.8 | 28.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.8 | 1.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.8 | 2.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.8 | 1.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.8 | 6.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 2.4 | GO:0043236 | laminin binding(GO:0043236) |
0.8 | 0.8 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.8 | 0.8 | GO:0016208 | AMP binding(GO:0016208) |
0.8 | 22.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.8 | 24.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.8 | 4.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.8 | 5.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.8 | 56.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.8 | 7.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 10.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.8 | 1.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 5.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.8 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.8 | 3.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.8 | 15.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.8 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 0.8 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.8 | 2.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.8 | 5.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.8 | 4.5 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.8 | 1.5 | GO:0002046 | opsin binding(GO:0002046) |
0.7 | 88.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.7 | 9.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.7 | 3.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 6.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 32.9 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.7 | 158.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.7 | 1.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 3.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 2.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 20.3 | GO:0042562 | hormone binding(GO:0042562) |
0.7 | 2.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.7 | 2.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.7 | 1.4 | GO:0022853 | active ion transmembrane transporter activity(GO:0022853) |
0.7 | 5.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 3.6 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.7 | 259.5 | GO:0005198 | structural molecule activity(GO:0005198) |
0.7 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 2.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 4.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 9.0 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.7 | 2.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 8.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 2.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.7 | 11.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.7 | 3.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 7.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.7 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.7 | 6.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.7 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 2.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 6.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.7 | 0.7 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.7 | 23.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.7 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 14.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.6 | 2.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.6 | 7.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 7.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 1.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 20.6 | GO:0004386 | helicase activity(GO:0004386) |
0.6 | 17.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.6 | 23.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.6 | 22.9 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.6 | 298.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.6 | 1.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.6 | 1.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.6 | 1.2 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.6 | 2.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 6.2 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.6 | 9.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 31.8 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.6 | 9.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.6 | 10.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.6 | 15.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.6 | 2.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.6 | 7.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 161.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.6 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 2.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 1.2 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.6 | 2.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 3.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.6 | 8.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.6 | 1.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.5 | 1.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.5 | 35.5 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 2.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 3.7 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.5 | 16.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.5 | 5.7 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.5 | 10.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.5 | 5.1 | GO:0033218 | amide binding(GO:0033218) |
0.5 | 0.5 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 7.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.5 | 3.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.5 | 3.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 6.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 0.5 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.5 | 6.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 75.6 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.5 | 1.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 10.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.5 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 0.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.5 | 3.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.5 | 0.9 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.5 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.4 | 0.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 17.4 | GO:0008233 | peptidase activity(GO:0008233) |
0.4 | 12.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.4 | 3.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 22.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.4 | 0.4 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 1.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.4 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 0.9 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.4 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 3.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.4 | 0.9 | GO:0016853 | isomerase activity(GO:0016853) |
0.4 | 16.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 8.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.4 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.4 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 33.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.4 | 2.0 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.4 | 5.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 0.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 0.7 | GO:0045182 | translation regulator activity(GO:0045182) |
0.4 | 18.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.3 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.3 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.3 | 7.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 1.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.3 | 0.3 | GO:0060229 | lipase activator activity(GO:0060229) |
0.3 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 3.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 5.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 0.3 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.3 | 0.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.9 | GO:0051861 | glycolipid binding(GO:0051861) |
0.3 | 0.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.3 | 36.1 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.3 | 0.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 3.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 2.9 | GO:0016874 | ligase activity(GO:0016874) |
0.3 | 200.0 | GO:0003677 | DNA binding(GO:0003677) |
0.3 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 1.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 0.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.3 | 1.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.2 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 14.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 31.2 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 80.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 3.2 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 1.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 1.0 | GO:0030234 | enzyme regulator activity(GO:0030234) |
0.2 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 7.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 1.4 | GO:1901618 | organic hydroxy compound transmembrane transporter activity(GO:1901618) |
0.2 | 10.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 219.8 | GO:0005515 | protein binding(GO:0005515) |
0.2 | 0.2 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.8 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.1 | GO:0019201 | guanylate kinase activity(GO:0004385) nucleotide kinase activity(GO:0019201) |
0.1 | 0.1 | GO:0016298 | lipase activity(GO:0016298) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.1 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 0.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 74.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 5.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 2.2 | GO:0046872 | metal ion binding(GO:0046872) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 362.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.7 | 80.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
4.6 | 60.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.3 | 114.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
4.2 | 104.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
4.2 | 4.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
4.1 | 8.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
4.1 | 78.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.7 | 3.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
3.6 | 134.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
3.5 | 177.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
3.5 | 17.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
3.3 | 82.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.2 | 3.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
3.1 | 24.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.0 | 32.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
2.9 | 14.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.8 | 5.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
2.7 | 24.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.7 | 53.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
2.7 | 10.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
2.6 | 125.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.6 | 102.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.5 | 61.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.5 | 63.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
2.5 | 2.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
2.5 | 70.1 | PID RHOA PATHWAY | RhoA signaling pathway |
2.5 | 54.9 | PID IFNG PATHWAY | IFN-gamma pathway |
2.4 | 14.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.4 | 79.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.4 | 4.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.4 | 30.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.3 | 27.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.3 | 20.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.2 | 22.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
2.2 | 6.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
2.2 | 37.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
2.1 | 10.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.1 | 106.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.1 | 41.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
2.1 | 20.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
2.0 | 12.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
2.0 | 69.5 | PID FOXO PATHWAY | FoxO family signaling |
2.0 | 16.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.0 | 21.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
2.0 | 15.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
2.0 | 37.4 | PID RAS PATHWAY | Regulation of Ras family activation |
1.9 | 51.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.9 | 7.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.8 | 47.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.8 | 21.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.7 | 15.7 | PID EPO PATHWAY | EPO signaling pathway |
1.7 | 1.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.7 | 6.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.7 | 34.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.7 | 20.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.7 | 13.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.7 | 40.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.7 | 15.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.7 | 6.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.6 | 34.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.6 | 18.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.6 | 57.1 | PID NOTCH PATHWAY | Notch signaling pathway |
1.6 | 1.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.6 | 17.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.6 | 4.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.5 | 51.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.5 | 23.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.5 | 7.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.5 | 18.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.5 | 34.5 | PID LKB1 PATHWAY | LKB1 signaling events |
1.5 | 198.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.5 | 8.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.4 | 5.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.4 | 27.4 | PID ARF6 PATHWAY | Arf6 signaling events |
1.4 | 25.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.4 | 42.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.4 | 12.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.4 | 16.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.3 | 12.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.3 | 12.1 | PID INSULIN PATHWAY | Insulin Pathway |
1.3 | 35.9 | PID AURORA B PATHWAY | Aurora B signaling |
1.3 | 6.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.3 | 14.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.3 | 11.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.3 | 43.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.3 | 34.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.3 | 7.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.3 | 22.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.2 | 12.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.2 | 7.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.2 | 4.9 | PID CDC42 PATHWAY | CDC42 signaling events |
1.2 | 24.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.2 | 25.2 | PID FGF PATHWAY | FGF signaling pathway |
1.2 | 2.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.2 | 10.7 | PID ALK2 PATHWAY | ALK2 signaling events |
1.2 | 29.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.2 | 13.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.2 | 2.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.2 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.1 | 1.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.1 | 7.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.1 | 10.0 | PID AURORA A PATHWAY | Aurora A signaling |
1.1 | 6.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.1 | 27.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 9.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.1 | 13.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.1 | 199.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.1 | 4.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.0 | 15.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.0 | 3.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.0 | 64.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.0 | 19.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.0 | 3.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.0 | 20.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.0 | 3.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 21.1 | PID P73PATHWAY | p73 transcription factor network |
1.0 | 5.0 | PID MYC PATHWAY | C-MYC pathway |
1.0 | 9.8 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 2.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.0 | 5.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 11.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.9 | 11.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.9 | 3.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.9 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.9 | 15.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.9 | 29.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.9 | 24.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.9 | 6.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.9 | 7.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 29.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 5.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 17.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 13.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 6.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 11.8 | PID BMP PATHWAY | BMP receptor signaling |
0.8 | 10.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.8 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 1.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 9.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 8.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.7 | 9.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 10.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.7 | 9.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.7 | 18.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 23.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 21.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.7 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 2.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 7.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 132.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.7 | 2.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 10.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.6 | 12.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 13.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.6 | 2.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 1.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 1.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 5.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 3.1 | PID ATM PATHWAY | ATM pathway |
0.4 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 1.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 6.9 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 3.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 168.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
9.3 | 93.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
8.9 | 125.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
8.8 | 70.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
8.5 | 161.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
7.3 | 87.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
6.1 | 12.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
5.8 | 75.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.8 | 34.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
5.7 | 11.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
5.4 | 54.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
5.3 | 31.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
5.2 | 52.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
5.2 | 72.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
5.0 | 50.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
4.5 | 27.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
4.3 | 12.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
4.2 | 59.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
4.2 | 58.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
4.1 | 20.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
4.1 | 70.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.9 | 110.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
3.7 | 100.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
3.7 | 7.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
3.7 | 55.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
3.5 | 77.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.5 | 52.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
3.4 | 31.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.4 | 34.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.3 | 9.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
3.3 | 43.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
3.3 | 36.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.3 | 42.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
3.3 | 13.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.2 | 41.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
3.2 | 48.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
3.1 | 3.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.1 | 27.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
3.0 | 142.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
3.0 | 3.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
3.0 | 3.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
3.0 | 89.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.9 | 41.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.9 | 2.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.9 | 29.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
2.9 | 123.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
2.9 | 57.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.8 | 113.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
2.8 | 2.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.8 | 14.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
2.8 | 8.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
2.7 | 21.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.7 | 16.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
2.7 | 27.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.7 | 73.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.7 | 18.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
2.7 | 29.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.7 | 18.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
2.7 | 79.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
2.6 | 107.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.6 | 23.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.6 | 41.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.6 | 33.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.5 | 22.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.5 | 24.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.5 | 24.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
2.4 | 19.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
2.4 | 41.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.4 | 26.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.4 | 71.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
2.4 | 2.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
2.3 | 32.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.3 | 32.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.3 | 64.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
2.3 | 4.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
2.3 | 38.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
2.3 | 11.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.3 | 38.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.2 | 35.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.2 | 58.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
2.2 | 20.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.2 | 64.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
2.2 | 19.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
2.2 | 37.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.2 | 26.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
2.2 | 15.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.2 | 17.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.1 | 23.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.1 | 10.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
2.1 | 2.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
2.1 | 29.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
2.1 | 8.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.0 | 24.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
2.0 | 4.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
2.0 | 20.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.0 | 2.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
2.0 | 26.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.9 | 27.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.9 | 42.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.9 | 28.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.9 | 15.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.9 | 13.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.9 | 148.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.9 | 20.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.9 | 18.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.9 | 48.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.8 | 27.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.8 | 9.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.8 | 38.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.8 | 60.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.8 | 19.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.8 | 10.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.8 | 37.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.8 | 50.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.8 | 117.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.8 | 14.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.8 | 35.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.7 | 8.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.7 | 11.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.7 | 99.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.7 | 1.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.7 | 25.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.6 | 11.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.6 | 9.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.6 | 57.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.6 | 8.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.6 | 3.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.6 | 7.9 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
1.6 | 99.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.6 | 6.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.6 | 43.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.5 | 6.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.5 | 71.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.5 | 1.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.5 | 4.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.5 | 12.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.5 | 19.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.5 | 12.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.5 | 4.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
1.5 | 17.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.5 | 92.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.5 | 26.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.5 | 5.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.4 | 56.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.4 | 10.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
1.4 | 12.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.4 | 15.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.4 | 15.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.4 | 14.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.4 | 9.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.4 | 18.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.4 | 5.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.4 | 24.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.4 | 16.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.3 | 5.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.3 | 23.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.3 | 121.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.3 | 7.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.3 | 53.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
1.3 | 10.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.3 | 7.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
1.3 | 2.6 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.3 | 24.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.3 | 3.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.3 | 20.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.2 | 15.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.2 | 2.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
1.2 | 30.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.2 | 1.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.2 | 4.8 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
1.2 | 32.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.2 | 16.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 16.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.2 | 16.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.1 | 2.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 6.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.1 | 27.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.1 | 35.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.1 | 3.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
1.1 | 19.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 23.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.1 | 5.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.1 | 8.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.1 | 21.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
1.1 | 53.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 8.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.0 | 12.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
1.0 | 5.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.0 | 15.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.0 | 10.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
1.0 | 6.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.0 | 5.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.0 | 16.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.0 | 2.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.0 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.0 | 18.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
1.0 | 5.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.9 | 10.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.9 | 14.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 0.9 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.9 | 1.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.9 | 2.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.9 | 0.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.9 | 20.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.9 | 4.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.9 | 10.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 9.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 4.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 11.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.8 | 101.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.8 | 8.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.8 | 9.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 22.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.8 | 4.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.8 | 90.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 9.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.8 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 3.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.8 | 8.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.8 | 3.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.8 | 5.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 6.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 3.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 8.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.7 | 4.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 7.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 6.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 0.7 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.6 | 7.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.6 | 3.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 1.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 1.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 1.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 3.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 50.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.6 | 15.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.6 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 56.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 1.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.5 | 9.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 6.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 24.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 6.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 4.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 1.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 1.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.5 | 2.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 18.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 4.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 4.1 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.5 | 0.9 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.5 | 1.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.5 | 1.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 1.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 14.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 5.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 4.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 1.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.4 | 8.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.4 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 8.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 0.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 5.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 5.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 4.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.3 | 1.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 1.2 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.3 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 1.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 2.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 1.6 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 5.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.2 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 0.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 1.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |